US20190270064A1 - Microcapsule compositions stabilized with viscosity control agent - Google Patents

Microcapsule compositions stabilized with viscosity control agent Download PDF

Info

Publication number
US20190270064A1
US20190270064A1 US16/334,038 US201716334038A US2019270064A1 US 20190270064 A1 US20190270064 A1 US 20190270064A1 US 201716334038 A US201716334038 A US 201716334038A US 2019270064 A1 US2019270064 A1 US 2019270064A1
Authority
US
United States
Prior art keywords
microcapsule
polyquaternium
composition
agent
acrylate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US16/334,038
Other languages
English (en)
Inventor
Djurre Sijbren Postma
Yabin Lei
Hui Min LEE
Daniel Kaiping Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
International Flavors and Fragrances Inc
Original Assignee
International Flavors and Fragrances Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by International Flavors and Fragrances Inc filed Critical International Flavors and Fragrances Inc
Priority to US16/334,038 priority Critical patent/US20190270064A1/en
Publication of US20190270064A1 publication Critical patent/US20190270064A1/en
Assigned to INTERNATIONAL FLAVORS & FRAGRANCES INC. reassignment INTERNATIONAL FLAVORS & FRAGRANCES INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LEE, Hui Min, POSTMA, DJURRE SIJBREN, Lee, Daniel Kaiping, LEI, YABIN
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/64—Macromolecular compounds not provided for by groups C08G18/42 - C08G18/63
    • C08G18/6415—Macromolecular compounds not provided for by groups C08G18/42 - C08G18/63 having nitrogen
    • C08G18/6423—Polyalkylene polyamines; polyethylenimines; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87—Polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/14—Polymerisation; cross-linking
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3225—Polyamines
    • C08G18/3228—Polyamines acyclic
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3225—Polyamines
    • C08G18/3228—Polyamines acyclic
    • C08G18/3231—Hydrazine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3225—Polyamines
    • C08G18/325—Polyamines containing secondary or tertiary amino groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3271—Hydroxyamines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/38—Low-molecular-weight compounds having heteroatoms other than oxygen
    • C08G18/3819—Low-molecular-weight compounds having heteroatoms other than oxygen having nitrogen
    • C08G18/3821—Carboxylic acids; Esters thereof with monohydroxyl compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/38—Low-molecular-weight compounds having heteroatoms other than oxygen
    • C08G18/3819—Low-molecular-weight compounds having heteroatoms other than oxygen having nitrogen
    • C08G18/3842—Low-molecular-weight compounds having heteroatoms other than oxygen having nitrogen containing heterocyclic rings having at least one nitrogen atom in the ring
    • C08G18/3848—Low-molecular-weight compounds having heteroatoms other than oxygen having nitrogen containing heterocyclic rings having at least one nitrogen atom in the ring containing two nitrogen atoms in the ring
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/64—Macromolecular compounds not provided for by groups C08G18/42 - C08G18/63
    • C08G18/6415—Macromolecular compounds not provided for by groups C08G18/42 - C08G18/63 having nitrogen
    • C08G18/6446—Proteins and derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/64—Macromolecular compounds not provided for by groups C08G18/42 - C08G18/63
    • C08G18/6484—Polysaccharides and derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/74—Polyisocyanates or polyisothiocyanates cyclic
    • C08G18/76—Polyisocyanates or polyisothiocyanates cyclic aromatic
    • C08G18/7657—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings
    • C08G18/7664—Polyisocyanates or polyisothiocyanates cyclic aromatic containing two or more aromatic rings containing alkylene polyphenyl groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/77—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur
    • C08G18/78—Nitrogen
    • C08G18/7806—Nitrogen containing -N-C=0 groups
    • C08G18/7818—Nitrogen containing -N-C=0 groups containing ureum or ureum derivative groups
    • C08G18/7831—Nitrogen containing -N-C=0 groups containing ureum or ureum derivative groups containing biuret groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/77—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur
    • C08G18/78—Nitrogen
    • C08G18/79—Nitrogen characterised by the polyisocyanates used, these having groups formed by oligomerisation of isocyanates or isothiocyanates
    • C08G18/791—Nitrogen characterised by the polyisocyanates used, these having groups formed by oligomerisation of isocyanates or isothiocyanates containing isocyanurate groups
    • C08G18/792—Nitrogen characterised by the polyisocyanates used, these having groups formed by oligomerisation of isocyanates or isothiocyanates containing isocyanurate groups formed by oligomerisation of aliphatic and/or cycloaliphatic isocyanates or isothiocyanates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/77—Polyisocyanates or polyisothiocyanates having heteroatoms in addition to the isocyanate or isothiocyanate nitrogen and oxygen or sulfur
    • C08G18/78—Nitrogen
    • C08G18/79—Nitrogen characterised by the polyisocyanates used, these having groups formed by oligomerisation of isocyanates or isothiocyanates
    • C08G18/791—Nitrogen characterised by the polyisocyanates used, these having groups formed by oligomerisation of isocyanates or isothiocyanates containing isocyanurate groups
    • C08G18/794—Nitrogen characterised by the polyisocyanates used, these having groups formed by oligomerisation of isocyanates or isothiocyanates containing isocyanurate groups formed by oligomerisation of aromatic isocyanates or isothiocyanates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/80—Masked polyisocyanates
    • C08G18/8003—Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen
    • C08G18/8006—Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32
    • C08G18/8009—Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32 with compounds of C08G18/3203
    • C08G18/8022—Masked polyisocyanates masked with compounds having at least two groups containing active hydrogen with compounds of C08G18/32 with compounds of C08G18/3203 with polyols having at least three hydroxy groups
    • C08G18/8029—Masked aromatic polyisocyanates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/04—Homopolymers or copolymers of esters
    • C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
    • C08L33/08—Homopolymers or copolymers of acrylic acid esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L61/00—Compositions of condensation polymers of aldehydes or ketones; Compositions of derivatives of such polymers
    • C08L61/20—Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen
    • C08L61/26—Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen of aldehydes with heterocyclic compounds
    • C08L61/28—Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen of aldehydes with heterocyclic compounds with melamine
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0008—Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
    • C11D17/0013—Liquid compositions with insoluble particles in suspension
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005—Other compounding ingredients characterised by their effect
    • C11D3/001—Softening compositions
    • C11D3/0015—Softening compositions liquid
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/50—Perfumes
    • C11D3/502—Protected perfumes
    • C11D3/505—Protected perfumes encapsulated or adsorbed on a carrier, e.g. zeolite or clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • C08L33/24—Homopolymers or copolymers of amides or imides
    • C08L33/26—Homopolymers or copolymers of acrylamide or methacrylamide
    • D—TEXTILES; PAPER
    • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
    • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
    • D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
    • D06M23/12—Processes in which the treating agent is incorporated in microcapsules

Definitions

  • Microcapsules are useful in a variety of applications where there is a need to deliver, apply, or release a fragrance or other active material in a time-delayed and controlled manner.
  • microcapsule compositions contain microcapsules dispersed in an aqueous phase. They tend to form gel, separate into layers, release the active material prematurely, etc. See US 2014/0287008 and WO 2015/023961. Certain microcapsule compositions have been developed to improve the stability via engineering a more robust microcapsule wall. See US 20140044760, WO2014011860, and US20130337023. However, these microcapsule compositions still face stability issues including short storage lifetime, gel formation during transportation in a harsh temperature, and instability in consumer products.
  • This invention is based on the discovery that certain viscosity control agents can stabilize microcapsule compositions.
  • one aspect of this invention relates to a microcapsule composition
  • a microcapsule composition comprising (i) a microcapsule suspended in an aqueous phase and (ii) a viscosity control agent, in which the viscosity control agent is an acrylate copolymer, a cationic acrylamide copolymer, or a polysaccharide.
  • acrylate copolymer examples include copolymers of acrylic acid and acrylate, acrylate/C 10 -C 30 alkyl acrylate cross-polymers, and combination thereof.
  • microcapsules include those having a microcapsule wall and a microcapsule core encapsulated by the microcapsule wall.
  • the microcapsule wall is typically formed of an encapsulating polymer selected from the group consisting of a polyacrylate, polyurea, polyurethane, polyacrylamide, polyester, polyether, polyamide, poly(acrylate-co-acrylamide), starch, silica, gelatin and gum Arabic, alginate, chitosan, polylactide, a melamine-formaldehyde polymer, poly(urea-formaldehyde), and combinations thereof.
  • the microcapsule core can contain an active material selected from the group consisting of a fragrance, pro-fragrance, flavor, malodor counteractive agent, vitamin or derivative thereof, anti-inflammatory agent, fungicide, anesthetic, analgesic, antimicrobial active, anti-viral agent, anti-infectious agent, anti-acne agent, skin lightening agent, insect repellant, animal repellent, vermin repellent, emollient, skin moisturizing agent, wrinkle control agent, UV protection agent, fabric softener active, hard surface cleaning active, skin or hair conditioning agent, flame retardant, antistatic agent, nanometer to micron size inorganic solid, polymeric or elastomeric particle, taste modulator, cell, probiotic, and combinations thereof.
  • an active material selected from the group consisting of a fragrance, pro-fragrance, flavor, malodor counteractive agent, vitamin or derivative thereof, anti-inflammatory agent, fungicide, anesthetic, analgesic, antimicrobial active, anti-viral agent, anti-infectious agent, anti
  • microcapsule compositions described above can further contain a dispersant such as a polyvinyl alcohol, polystyrene sulfonate, carboxymethyl cellulose, sodium polystyrene sulfonate, alkylnaphthalenesulfonate formaldehyde condensate, polyvinylpyrrolidone, copolymer of vinyl pyrrolidone and quaternized dimethylaminoethyl methacrylate, and combinations thereof.
  • a dispersant such as a polyvinyl alcohol, polystyrene sulfonate, carboxymethyl cellulose, sodium polystyrene sulfonate, alkylnaphthalenesulfonate formaldehyde condensate, polyvinylpyrrolidone, copolymer of vinyl pyrrolidone and quaternized dimethylaminoethyl methacrylate, and combinations thereof.
  • the polyurea is usually a reaction product of a polyfunctional isocyanate and a polyfunctional amine in the presence of an alkylnaphthalenesulfonate formaldehyde condensate and polyvinylpyrrolidone
  • the polyurethane is a reaction product of a polyfunctional isocyanate and a polyfunctional alcohol as a cross-linking agent in the presence of an alkylnaphthalenesulfonate formaldehyde condensate and polyvinylpyrrolidone.
  • Suitable polyfunctional isocyanates include, but are not limited to, an aromatic polyfunctional isocyanate, aliphatic polyfunctional isocyanate, or combination thereof.
  • aromatic polyfunctional isocyanate contain a phenyl, tolyl, xylyl, naphthyl, or diphenyl moiety, or a combination thereof, such as polymeric methylene diphenyl diisocyanate, polyisocyanurates of toluene diisocyanate, trimethylol propane-adducts of toluene diisocyanate, trimethylol propane-adducts of xylylene diisocyanate, and combinations.
  • Nonlimiting examples of the aliphatic polyfunctional isocyanate include trimers (symmetric or asymmetric) of hexamethylene diisocyanate, trimers of isophorone diisocyanate, biurets of hexamethylene diisocyanate, and combinations thereof.
  • Exemplary polyfunctional amines are hexamethylenediamine, hexaethylenediamine, ethylenediamine, 1,3-diaminopropane, 1,4-diamino-butane, diethylenetriamine, pentaethylenehexamine, 1,6-diaminohexane, hydrazine, 1,4-diaminocyclohexane and 1,3-diamino-1-methylpropane, bis(3-aminopropyl)amine, bis(hexamethylene)triamine, tris(2-aminoethyl)amine, triethylene-tetramine, N,N′-bis(3-aminopropyl)-1,3-propanediamine, tetraethylenepentamine, branched polyethylenimine, chitosan, nisin, gelatin, 1,3-diamino-guanidine, 1,1-dimethylbiguanide, guanidine, argin
  • alkylnaphthalenesulfonate formaldehyde condensate and polyvinylpyrrolidone are used as the dispersant, each of them can be, independently, present at a level of 0.1 to 5% by weight of the microcapsule composition.
  • the ratio between the alkylnaphthalenesulfonate formaldehyde condensate and polyvinylpyrrolidone can range from 10:1 to 1:10.
  • the encapsulating polymer can be a polyurea that is a reaction product of a polyisocyanate and a polyamine, in which the polyisocyanate contains a trimethylol propane-adduct of toluene diisocyanate or a trimethylol propane-adduct of xylylene diisocyanate, and the polyamine is diethylenetriamine, bis(3-aminopropyl)amine, bis(hexamethylene)triamine, tris-(2-aminoethyl)amine, triethylenetetramine, N,N′-bis(3-aminopropyl)-1,3-propanediamine, tetraethylene-pentamine, pentaethylenehexamine, branched polyethylenimine, chitosan, nisin, gelatin, 1,3-diaminoguanidine monohydrochloride, 1,1-dimethylbiguanide hydrochloride, guanidine carbonate, or a mixture
  • microcapsule compositions can further comprise a polyvinyl alcohol, polystyrene sulfonate, carboxymethyl cellulose, alkylnaphthalenesulfonate formaldehyde condensate, copolymer of vinyl pyrrolidone and quaternized dimethylaminoethyl methacrylate, or combination thereof.
  • the microcapsule compositions contains a stabilizing agent selected from the group consisting of hexamethylene diamine, hexaethylenediamine, ethylenediamine, 1,3-diaminopropane, 1,4-diamino-butane, diethylenetriamine, pentaethylenehexamine, bis(3-aminopropyl)amine, bis(hexamethylene)triamine, tris(2-aminoethyl)amine, triethylene-tetramine, N,N′-bis(3-aminopropyl)-1,3-propanediamine, tetraethylenepentamine, branched polyethylenimine, chitosan, nisin, gelatin, 1,3-diamino-guanidine, 1,1-dimethylbiguanide, guanidine, arginine, lysine, ornithine, histidine, amino-2-methyl-1-propanol, 5-chloro-2-methyl-4-
  • a deposition aid is also an optional component in the microcapsule compositions.
  • Examples include polyquaternium-4, polyquaternium-5, polyquaternium-6, polyquaternium-7, polyquaternium-10, polyquaternium-16, polyquaternium-22, polyquaternium-24, polyquaternium-28, polyquaternium-39, polyquaternium-44, polyquaternium-46, polyquaternium-47, polyquaternium-53, polyquaternium-55, polyquaternium-67, polyquaternium-68, polyquaternium-69, polyquaternium-73, polyquaternium-74, polyquaternium-77, polyquaternium-78, polyquaternium-79, polyquaternium-80, polyquaternium-81, polyquaternium-82, polyquaternium-86, polyquaternium-88, polyquaternium-101, polyvinylamine, polyethyleneimine, polyvinylamine and vinylformamide copolymer, and combinations thereof.
  • the microcapsule composition further contains one or more free fragrances (e.g., a first, second, third, and/or fourth fragrances) and/or one or more additional microcapsules (e.g., a second, third, and/or fourth microcapsules).
  • one or more free fragrances e.g., a first, second, third, and/or fourth fragrances
  • one or more additional microcapsules e.g., a second, third, and/or fourth microcapsules.
  • the encapsulating polymer is a melamine-formaldehyde polymer including a melamine-formaldehyde polymer crosslinked with an acrylate copolymer such as poly(acrylic acid-acrylamide) and poly(acrylic acid-acrylate).
  • the viscosity control agent is a copolymer of acrylic acid and acrylate present at a level of 0.1 to 5% (e.g., 0.2 to 2%) by weight of the microcapsule composition.
  • the viscosity control agent is xanthan gum, which is a polysaccharide.
  • microcapsule compositions described above can be in a slurry or a solid form.
  • the latter is typically prepared by drying such as spray drying.
  • a consumer product containing the above-described microcapsule composition.
  • exemplary consumer products are a shampoo, a hair conditioner, a hair rinse, a hair refresher, a hair fixative or styling aid, a hair bleach, a hair dye or colorant, a soap, a body wash, a cosmetic preparation, an all-purpose cleaner, a bathroom cleaner, a floor cleaner, a window cleaner, a bath tissue, a paper towel, a disposable wipe, a diaper rash cream or balm, a baby powder, a diaper, a bib, a baby wipe, an oral care product, a tooth paste, an oral rinse, an tooth whitener, a denture adhesive, a chewing gum, a breath freshener, an orally dissolvable strips, a chewable candy, a hard candy, a hand sanitizer, an anti-inflammatory balm, an anti-inflammatory ointment, an anti-inflammatory spray, a health care device, a dental floss, a toothbrush,
  • capsule and “microcapsule” herein are used interchangeably.
  • g gram
  • milligram gram
  • microgram gram
  • L liter
  • milliliter liter
  • microcapsule compositions are stabilized by a viscosity control agent for at least 4 weeks (e.g., at least 6 weeks, at least 8 weeks, 4 weeks to two years, 4 week to one year, and 4 to 26 weeks) when being stored at 25 or 45° C.
  • a viscosity control agent for at least 4 weeks (e.g., at least 6 weeks, at least 8 weeks, 4 weeks to two years, 4 week to one year, and 4 to 26 weeks) when being stored at 25 or 45° C.
  • the stability is measure by both the viscosity and water separation.
  • Known microcapsule compositions tend to form into gels, making them unsuitable for use in consumer products.
  • the viscosity of the composition increases to 3000 centipoise (cP) or greater 6000 cP.
  • the microcapsule is considered stable if it does not gel out and has a viscosity of 3000 cP or less (e.g., 2500 cP or less and 2000 cP or less).
  • the microcapsule composition is emulsion-like dispersion (i.e., a colloidal suspension) in which the microcapsules are evenly dispersed in the water phase. Over storage, the microcapsules can flocculate and water can separate out from the composition. Such separation will require additional process to turn the composition to a homogenous suspension, during which undesirable microcapsule bursting and fragrance leakage are observed.
  • the microcapsule composition is deemed stable if 20% or less (e.g., 10% or less and 5% or less) water by volume of the composition is separated.
  • the microcapsule composition of this invention is a microcapsule slurry containing one or more microcapsules dispersed in an aqueous phase.
  • the one or more microcapsules each have a microcapsule core and a microcapsule wall encapsulating the microcapsule core.
  • the microcapsule wall is free of a viscosity control agent, e.g., an acrylate copolymer (such as a copolymer of acrylic acid and acrylate, and acrylate/C 10 -C 30 alkyl acrylate cross-polymer), a cationic acrylamide copolymer, or a polysaccharide (such as xanthan gum).
  • a viscosity control agent e.g., an acrylate copolymer (such as a copolymer of acrylic acid and acrylate, and acrylate/C 10 -C 30 alkyl acrylate cross-polymer), a cationic acrylamide copolymer, or a polysaccharide (such as xanthan gum).
  • the microcapsule is present at a level of 10 to 70% (e.g., 20 to 70% and 30 to 60%) by weight of the stable microcapsule compositions described above.
  • the viscosity control agent is not part of the microcapsule wall. It is dispersed homogenously in the aqueous phase and stays outside of the microcapsule wall. In some embodiments, the viscosity control agent is present at a level of 0.01 to 10% (e.g., 0.1 to 5%, 0.2 to 5%, 0.2 to 2%, 0.5 to 1.5%, 0.01 to 0.1%, and 0.02 to 0.05%).
  • microcapsule compositions of this invention typically have a pH value of 2-10 (e.g., 3-9, 4-8, 5-8, and 6-7.5).
  • the pH value can be adjusted by adding an acid or base.
  • microcapsule compositions of this invention find their utility in a wide range of consumer applications, e.g., personal care products including shampoos, hair conditioners, hair rinses, hair refreshers; personal wash such as bar soaps, body wash, personal cleaners and sanitizers, hydro-alcoholic formulations; fabric care such as fabric refreshers, softeners and dryer sheets, ironing water, industrial cleaners, liquid and powder detergent including unit dose capsules, rinse conditioners, and scent booster products; fine fragrances; an Eau De Toilette products; deodorants; roll-on products, and aerosol products.
  • personal care products including shampoos, hair conditioners, hair rinses, hair refreshers
  • personal wash such as bar soaps, body wash, personal cleaners and sanitizers, hydro-alcoholic formulations
  • fabric care such as fabric refreshers, softeners and dryer sheets, ironing water, industrial cleaners, liquid and powder detergent including unit dose capsules, rinse conditioners, and scent booster products
  • fine fragrances an Eau De Toilette products; deodorants; roll-
  • microcapsule composition The components of the microcapsule composition are described in detail below.
  • Any viscosity control agent can be used in this invention. It is added to the microcapsule composition to achieve a desired viscosity of the composition so that the microcapsule is dispersed in the composition for a pro-longed period of time.
  • the viscosity control agent typically disperses homogeneously in the microcapsule slurry and outside of the microcapsule wall of the microcapsules in the composition of this invention.
  • Suitable viscosity control agents include an acrylate copolymer, a cationic acrylamide copolymer, a polysaccharide, or a combination thereof.
  • acrylate copolymers include those under the trade name ACULYNTM (from Dow Chemical Company) such as ACULYNTM 22 (a copolymer of acrylates and stearth-20 methacrylate), ACULYNTM 28 (a copolymer of acrylate and beheneth-25 methacrylate), ACULYNTM 33 (a copolymer of acrylic acid and acrylate), ACULYNTM 38 (a crosspolymer of acrylate and vinyl neodecanoate), and ACULYNTM 88 (a crosspolymer of acrylate and steareth-20 methacrylate).
  • ACULYNTM 22 a copolymer of acrylates and stearth-20 methacrylate
  • ACULYNTM 28 a copolymer of acrylate and beheneth-25 methacrylate
  • ACULYNTM 33 a copolymer of acrylic acid and acrylate
  • ACULYNTM 38 a crosspolymer of acrylate and vinyl ne
  • Particularly useful acrylate copolymers are anionic acrylate copolymer such as ACULYNTM 33, an alkali-soluble anionic acrylic polymer emulsion (ASE), which is synthesized from acrylic acid and acrylate comonomers through emulsion polymerization.
  • ACULYNTM 33 contains 28% of the polymer in water, has a pH of 3, a density of 1.05 g/mL, an equivalent weight of 218 (the equivalent weight refers to grams of dry polymer neutralized by 1 equivalent, i.e., 40 grams of sodium hydroxide), and a viscosity of 10 cP.
  • the acrylate copolymer has the following structure:
  • R 1 is H or a C 1 -C 24 (e.g., C 1 -C 10 and C 1 -C 6 ) alkyl
  • R2 is a C 1 -C 24 (e.g., C 1 -C 10 and C 1 -C 6 ) alkyl
  • x is an integer selected from 1-4100
  • y is an integer selected from 1-4100.
  • the molecular weight of the acrylate copolymer is 200-10000000 (e.g., 500-5000000, 1000-1000000, and 2000 to 500000).
  • Carbopol® polymers are also suitable acrylate copolymer useful in this invention. Examples are Carbopol® ETD 2020 polymer (a crosspolymer of acrylate and C 10 -C 30 alkyl acrylate), Carbopol® ETD 2691, Carbopol® ETD 2623 (a crosslinked acrylate copolymer),
  • Carbomer (polyacrylic acid) can also be used as viscosity control agents.
  • Carbomer codes (672, 690, 910, 934, 934P, 940, 941, 1342, 1662) are an indication of molecular weight and the specific components of the polymer. Their molecular weight ranges from 100000 to 3,000,000 (Carbomer 672, M.W. 3,000,000; Carbomer 910, M.W., 750,000; Carbomer 934, M.W., 500000; Carbomer 940, M.W. 4000000; Carbomer 941, M.W. 1250000; and Carbomer 1662, M.W., 4,000,000).
  • Carbomer polymers are commercially available, e.g., under the trade name Carbopol® from Lubrizol Corporation.
  • Polysaccharides are another class of agents suitable for viscosity control agents. Commonly used polysaccharides include starches, pectin, and vegetable gums such as alginin, guar gum, locust bean gum, and xanthan gum (e.g., Keltrol® T, 80-mesh food-grade, commercially available from CP Kelco, Atlanta, Ga.).
  • Cationic acrylamide copolymers can also be used as viscosity control agents. These cationic cross-linked polymers are derivable from the polymerization of from 5 to 100 mole percent of cationic vinyl addition monomer, from 0 to 95 mole percent of acrylamide and from 50 to 1000 ppm of a difunctional vinyl addition monomer cross-linking agent. Preferred polymers are cross-linked copolymers of acrylamide and methacrylate cross-linked with a difunctional vinyl addition monomer, such as methylene bisacrylamide.
  • the cationic acrylamide copolymer is a cationic copolymer obtained by Hofmann rearrangement in aqueous solution in the presence of an alkali and/or alkaline earth hydroxide and an alkali and/or alkaline earth hypohalide, on a base copolymer comprising: (i) at least 5 mole % of a non-ionic monomer selected from the group consisting of acrylamide, methacrylamide, N,N-dimethylacrylamide, acrylonitrile, and combinations thereof; and (ii) at least one comonomer selected from the group consisting of unsaturated cationic ethylenic comonomer, non-ionic comonomer, or combinations thereof, provided that
  • the cationic copolymer thus obtained has a desalination coefficient (Cd) of greater than 0.6 (e.g., greater than 0.65 and greater than 0.7).
  • Cd is calculated as Real polymeric active matter (% by weight of the copolymer) ⁇ Polymer filler density Conductivity of the solution containing 9% of active matter. See also U.S. Pat. No. 8,242,215.
  • the unsaturated cationic ethylenic comonomer can be selected from the group consisting of dialkylaminoalkyl(meth)acrylamide monomers, diallylamine monomers, methyldiallylamine monomers, and quaternary ammonium salts or acids thereof, such as dimethyldiallylammonium chloride (DADMAC), acrylamidopropyltrimethyl-ammonium chloride (APTAC), methacrylamidopropyltrimethylammonium chloride (MAPTAC).
  • DMDMAC dimethyldiallylammonium chloride
  • ATAC acrylamidopropyltrimethyl-ammonium chloride
  • MATAC methacrylamidopropyltrimethylammonium chloride
  • non-ionic comonomer are N-vinyl acetamide, N-vinyl formamide, N-vinylpyrrolidone, vinyl acetate, and combinations thereof.
  • the base copolymer is preferably branched in the presence of a branching agent selected from the group consisting of methylene bisacrylamide, ethylene glycol di-acrylate, polyethylene glycol dimethacrylate, diacrylamide, cyanomethylacrylate, vinyloxyethylacrylate, vinyloxyethylmethacrylate, triallylamine, formaldehyde, glyoxal, and a glycidylether type compound. More examples of the cationic acrylamide copolymers can be found in U.S. Pat. No. 8,242,215. Such materials are commercially available from SNF Floerger under the trade names Flosoft FS 200, Flosoft FS 222, and Flosoft FS 228. See also WO 2007141310, US 20060252668, and US 20100326614.
  • the molecular weight of the polymeric viscosity control agent varies from 1000 to 10000000 (e.g., 2000 to 6000000, 3000 to 5000000, 10000 to 5000000, and 50000 to 5000000).
  • the amount of the viscosity control agent can be any desired amount to obtain the desired viscosity of the composition. In certain embodiments, the amount is 0.01 to 20% by weight of the composition. In other embodiments, the amount is 0.1 to 10%, 0.2 to 8%, 0.2 to 5%, 0.28 to 1.4%, and 0.021 to 0.045%.
  • a person skilled in the art can determine the amount of the viscosity control agent needed so that the microcapsule composition has a viscosity that allows the composition to be pourable, which is usually below 10 Pa ⁇ s (e.g., less than 5 Pa ⁇ s, less than 1.5 Pa ⁇ s, less than 1 Pa ⁇ s, less than 0.750 Pa ⁇ s, less than 0.500 Pa ⁇ s, less than 0.100 Pa ⁇ s, less than 0.080, and less than 0.075 Pa ⁇ s). Viscosity is measured following standard procedures in the art, e.g., using a Brookfield RVT Viscometer equipped with spindle 2 at 20 RPM at 25° C.
  • negatively charged clays can also be used as viscosity control agents. These clays contain fine particles having a net negative electrostatic charge on at least one surface of their sheets. The surface charge is usually balanced by the presence of charge balancing ions (sometimes called exchangeable ions, e.g., sodium and calcium) which are usually present between the layers of the clay and at the edges of the layers.
  • charge balancing ions sometimes called exchangeable ions, e.g., sodium and calcium
  • Preferred negatively charged clays are 2:1 phyllosilicates, in which the clay layers comprise two tetrahedral sheets sandwiching one octahedral sheet.
  • Examples are smectite clays having the general formula Al 2 (Si 2 O 5 ) 2 (OH) 2 .nH 2 O or Mg 3 (Si 2 O 5 ) 2 (OH) 2 .nH 2 O, and derivatives thereof, for example in which a proportion of the aluminum ions are replaced with magnesium ions or a proportion of the magnesium ions are replaced with lithium ions and/or some of the hydroxyl ions are replaced by fluoride ions; the derivatives may comprise a further metal ion to balance the overall charge.
  • smectite clays herein include both the clays in which aluminum oxide is present in a silicate lattice and the clays in which magnesium oxide is present in a silicate lattice.
  • Typical smectite clay compounds include the dioctahedral minerals montmorillonite, beidellite, volchonskoites, and nontronite, and the trioctahedral minerals hectorite, saponite, and sauconite, particularly those having an alkali or alkaline earth metal ion within the crystal lattice structure.
  • Preferred smectite clays are montmorillonite clays.
  • the montmorillonite clays typically have the general formula HAlSi 2 O 6 but with variable Al—Si ratios, variable amounts of water and usually containing variable amounts of exchangeable cations. These clays can have alkali and alkaline earth metal cations as exchangeable ions. Examples include sodium and calcium montmorillonites. Another exemplary montmorillonite clay is an aluminous member of the group accorded the empirical Formula (OH) 4 Si 8 (Al 3.34 Mg 0.66 Na 0.66 )O 20 . Both bentonite and hectorite are also members of the montmorillonite clays.
  • montmorillonite clays include GELWHITE series (highly purified montmorillonite clays) marketed as GELWHITE-GP, GELWHITE-H, and GELWHITE-L by BYK Additives & Instruments, Germany.
  • Examples of synthetic hectorites useful in the present invention include those products sold under the trade names Laponite RD, Laponite RDS, Laponite XLG, Laponite XLS, Laponite D, Laponite DF, Laponite DS, Laponite S and Laponite JS (all from Southern Clay products, Texas, USA, a subsidiary of Rockwood).
  • Clays may be used as obtained from the supplier and may contain conventional additives such as, for example, disintegrating agents (also known as peptisers) and water of hydration.
  • the clays may be used in their natural state or in a purified or semi-purified form, for example with the removal of mineral impurities.
  • the cation exchange capacity (CEC) of a clay is a well-known parameter and may be determined by well-established analytical techniques, including by electrodialysis, by exchange with ammonium ion followed by titration or by a methylene blue procedure, all as fully described in Grimshaw, “The Chemistry and Physics of Clays”, pp. 264-265, Interscience (1971). It is customary to measure the cation exchange capacity of a clay in terms of milliequivalents per 100 g of dry clay (meq/100 g).
  • Preferred clays for use in the present invention have a cation exchange capacity of from 0.7 meq/100 g to 150 meq/100 g (e.g., 30 meq/100 g to 100 meq/100 g).
  • the clays preferably have a volume-based median particle diameter (D0.5) from 0.001 ⁇ m to 80 ⁇ m (e.g., 0.01 ⁇ m to 50 ⁇ m, 0.02 ⁇ m to 20 ⁇ m, and 0.05 to 5 ⁇ m). Particle diameters can be determined using a Malvern Mastersizer (Malvern Instruments, UK).
  • the permanent charges of the silicate layers in the clay particles result from isomorphous substitutions.
  • the degree of substitution changes from layer to layer within certain limits so that the interlayer cation density also varies from interlayer space to interlayer space and may also vary in directions parallel to the layers (heterogeneous charge distribution).
  • the distribution of the interlayer cation density can easily be determined by the alkylammonium method as described in Mermut and Lagaly, Clays and Clay Minerals 49 (2001), 393-397.
  • the average layer charge of montmorillonite clays varies between 0.2 and 0.4 eq/formula unit (Si, A1) 4 O 10 .
  • Some montmorillonite clays have an average layer charges around 0.3 eq/formula unit.
  • the surface charge can be in the range of 0.01 to 2 Coulomb/m 2 (“Cm ⁇ 2 ”) (e.g., 0.02 to 1 Cm ⁇ 2 and 0.05 to 0.5 Cm ⁇ 2 ).
  • the level of the clay in the total composition is preferably from 0.01 to 10 wt % of the total composition (e.g., 0.05 to 2 wt %, 0.05 to 1%, 0.1 to 0.5%, and 0.1 to 0.3%).
  • the clay is advantageously present in the form of a dispersion (for example a sol or gel) or as a suspension.
  • PQ polyquaternium (hereinafter “PQ”) polymers can also be added to any of the microcapsule compositions described above.
  • the PQ polymers are not viscosity control agents. They are used in combination with clays or other polymers described above. These polymers are often added to the composition of this invention as a deposition aid to assist the fragrance-containing microcapsules to deposit on treated surfaces such as textiles, hairs, furniture, floors, and skins.
  • Suitable cationic polymers are cationic polyquaternium polymers such as those listed in Table 1 below.
  • Preferred cationic polymers include a hydroxylethyl cellulose dimethyl diallylammonium chloride copolymer (PQ-4), a copolymer of acrylamide and diallyldimethylammonium chloride (PQ-7), a terpolymer of acrylic acid, methacrylamidopropyl trimethylammonium chloride, and methyl acrylate (PQ-47), and combinations thereof.
  • Microcapsules can be prepared following encapsulation procedures known in the art. See for example U.S. Pat. Nos. 2,800,457, 3,870,542, 3,516,941, 3,415,758, 3,041,288, 5,112,688, 6,329,057, and 6,261,483.
  • microcapsules contains a microcapsule wall encapsulating a microcapsule core wherein the microcapsule wall is formed of an encapsulating polymer and the microcapsule core contains an active material.
  • Another type of microcapsules are the so-called reloadable microcapsules wherein the microcapsule core contains a sacrifice solvent and is free of an active material.
  • Wall forming materials include a melamine formaldehyde, polyurethane, polysiloxanes, polyurea, polyamide, polyimide, polyvinyl alcohol, polyanhydride, polyolefin, polysulfone, polysaccharide, protein, polypeptide, polylactide (PLA), polyglycolide (PGA), polyorthoester, polyphosphazene, silicone, lipid, modified cellulose, gum, polystyrene, polyester, polyether, and combination of these materials.
  • a melamine formaldehyde polyurethane, polysiloxanes, polyurea, polyamide, polyimide, polyvinyl alcohol, polyanhydride, polyolefin, polysulfone, polysaccharide, protein, polypeptide, polylactide (PLA), polyglycolide (PGA), polyorthoester, polyphosphazene, silicone, lipid, modified cellulose, gum, polystyrene, polyester, poly
  • polymeric materials that are functional are ethylene maleic anhydride copolymer, styrene maleic anhydride copolymer, ethylene vinyl acetate copolymer, and lactide glycolide copolymer.
  • Biopolymers that are derived from alginate, chitosan, collagen, dextran, gelatin, and starch can also be used as the encapsulating materials. Additionally, capsules can be made via the simple or complex coacervation of gelatin.
  • Preferred encapsulating wall polymers include those formed from isocyanates, acrylates, acrylamide, acrylate-co-acrylamide, hydrogel monomers, sol-gel precursors, gelatin, melamine-formaldehyde or urea-formaldehyde condensates, as well as similar types of aminoplasts.
  • microcapsules and encapsulating polymers are described below as non-limiting examples.
  • Polyurea capsules each have a microcapsule wall formed of an encapsulating polymer that is the polymerization reaction product of a polyisocyanate and a polyamine/polyalcohol.
  • an encapsulating polymer that is the polymerization reaction product of a polyisocyanate and a polyamine/polyalcohol.
  • WO 2004/054362 EP 0 148149; EP 0 017 409 B1; U.S. Pat. Nos. 4,417,916, 4,124,526, 4,285,720, 4,681,806, 5,583,090, 6,340,653 6,566,306, 6,730,635, 8,299,011, WO 90/08468, and WO 92/13450.
  • the encapsulating polymer can also be prepared using a carbonyl crosslinker and a polyamine/polyalcohol.
  • the polyisocyanates each contain two or more isocyanate (—NCO) groups.
  • Suitable polyisocyanates include, for example, 1,5-naphthylene diisocyanate, 4,4′-diphenylmethane diisocyanate (MDI), hydrogenated MDI (H12MDI), xylylene diisocyanate (XDI), tetramethylxylol diisocyanate (TMXDI), 4,4′-diphenyldimethylmethane diisocyanate, di- and tetraalkyldiphenylmethane diisocyanate, 4,4′-dibenzyl diisocyanate, 1,3-phenylene diisocyanate, 1,4-phenylene diisocyanate, the isomers of tolylene diisocyanate (TDI), optionally in a mixture, 1-methyl-2,4-diisocyanatocyclohexane, 1,6-diisocyanato-2
  • Sulfur-containing polyisocyanates are obtained, for example, by reacting hexamethylene diisocyanate with thiodiglycol or dihydroxydihexyl sulfide.
  • Further suitable diisocyanates are trimethylhexamethylene diisocyanate, 1,4-diisocyanatobutane, 1,2-diisocyanatododecane, dimer fatty acid diisocyanate, and combinations thereof.
  • polyisocyanates include LUPRANATE M20 (PMDI, commercially available from BASF containing isocyanate group “NCO” 31.5 wt %), where the average n is 0.7; PAPI 27 (PMDI commercially available from Dow Chemical having an average molecular weight of 340 and containing NCO 31.4 wt %) where the average n is 0.7; MONDUR MR (PMDI containing NCO at 31 wt % or greater, commercially available from Bayer) where the average n is 0.8; MONDUR MR Light (PMDI containing NCO 31.8 wt %, commercially available from Bayer) where the average n is 0.8; MONDUR 489 (PMDI commercially available from Bayer containing NCO 30-31.4 wt %) where the average n is 1.0; poly[(phenylisocyanate)-co-formaldehyde] (Aldrich Chemical, Milwaukee, Wis.), other isocyanate monomers
  • the polyisocyanate used in the preparation of the capsules of this invention is a single polyisocyanate.
  • the polyisocyanate is a mixture of polyisocyanates.
  • the mixture of polyisocyanates includes an aliphatic polyisocyanate and an aromatic polyisocyanate.
  • the mixture of polyisocyanates is a biuret of hexamethylene diisocyanate and a trimethylol propane-adduct of xylylene diisocyanate.
  • the polyisocyanate is an aliphatic isocyanate or a mixture of aliphatic isocyanate, free of any aromatic isocyanate. In other words, in these embodiments, no aromatic isocyanate is used to prepare the polyurea/polyurethane polymers as capsule wall materials.
  • the average molecular weight of certain suitable polyisocyanates varies from 250 to 1000 Da and preferable from 275 to 500 Da.
  • the range of the polyisocyanate concentration varies from 0.1% to 10%, preferably from 0.1% to 8%, more preferably from 0.2 to 5%, and even more preferably from 1.5% to 3.5%, all based on the weight of the capsule delivery system.
  • Suitable polyisocyanates can be found in WO 2004/054362; WO 2015/023961; EP 0 148149; EP 0 017 409 B1; U.S. Pat. Nos. 4,417,916, 4,124,526, 5,583,090, 6,566,306, 6,730,635, PCT 90/08468, PCT WO 92/13450, U.S. Pat. Nos. 4,681,806, 4,285,720 and 6,340,653.
  • the carbonyl crosslinkers each have at least two functional groups, e.g., a first functional group and a second functional group.
  • the first functional group is an electrophilic group reactive towards the polyfunctional amine or the polyfunctional alcohol to form a network of the encapsulating polymer.
  • Examples include formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, a carboxylic anhydride group, an alkyl halide group, an epoxide group, an aziridine group, an oxetane group, an azetidine group, a sulfonyl halide group, a chlorophosphate group, an isocyanate group, an ⁇ , ⁇ -unsaturated carbonyl group, an ⁇ , ⁇ -unsaturated nitrile group, or an ⁇ , ⁇ -unsaturated methanesulfonyl group.
  • the first function group is a carbonyl electrophilic group containing a carbonyl group such as formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, a carboxylic anhydride group, an ⁇ , ⁇ -unsaturated carbonyl group, a trifluoromethanesulfonate group, and a p-toluenesulfonate group.
  • a carbonyl group such as formyl, keto, carboxyl, a carboxylate ester group, an acyl halide group, an amide group, a carboxylic anhydride group, an ⁇ , ⁇ -unsaturated carbonyl group, a trifluoromethanesulfonate group, and a p-toluenesulfonate group.
  • the second functional group is an electrophilic group reactive towards the polyfunctional amine or the polyfunctional alcohol. It can be selected from the groups listed immediately above.
  • Examples of a carbonyl crosslinker include glutaric dialdehyde, succinic dialdehyde, and glyoxal; as well as compounds such as glyoxyl trimer and paraformaldehyde, bis(dimethyl) acetal, bis(diethyl) acetal, polymeric dialdehydes, such as oxidized starch.
  • the cross-linking agent is a low molecular weight, difunctional aldehyde, such as glyoxal, 1,3-propane dialdehyde, 1,4-butane dialdehyde, 1,5-pentane dialdehyde, or 1,6-hexane.
  • Suitable polyfunctional amines include those described in WO 2015/023961. Examples are hexamethylenediamine, hexaethylenediamine, ethylenediamine, 1,3-diaminopropane, 1,4-diamino-butane, diethylenetriamine, pentaethylenehexamine, bis(3-aminopropyl)amine, bis(hexamethylene)triamine, tris(2-aminoethyl)amine, triethylene-tetramine, N,N′-bis(3-aminopropyl)-1,3-propanediamine, tetraethylenepentamine, amino-2-methyl-1-propanol, chitosan, 1,3-diamino-guanidine, 1,1-dimethylbiguanide, guanidine, arginine, lysine, histidine, ornithine, nisin, gelatin, and combinations thereof.
  • polyethylenimine polyethylenimine and branched polyethylenimine (“BPEI”). Representative BPEI structure is shown below:
  • BPEI for use in this invention preferably has a molecular weight of 500 to 5,000,000 Daltons (e.g., 500 to 1,000,000 Daltons, 750 to 500,000 Daltons, 750 to 100,000 Daltons, and 750 to 50,000 Daltons).
  • BPEI are commercially available from Sigma-Aldrich (St. Louis, Mo.; average molecular weight 25,000 Daltons) and Polysciences Inc. (Warrington, Pa.; various products having molecular weight of 600, 1200, 1800, 10,000, 70,000, 750,000, 250,000, and 2,000,000 Daltons).
  • Suitable polyfunctional alcohols are also described in WO 2015/023961. Examples include pentaerythritol, dipentaerythritol, glycerol, polyglycerol, ethylene glycol, polyethylene glycol, trimethylolpropane, neopentyl glycol, sorbitol, erythritol, threitol, arabitol, xylitol, ribitol, mannitol, galactitol, fucitol, iditol, inositol, volemitol, isomalt, maltitol, lactitol, maltotriitol, maltotetraitol, polyglycitol, and combinations thereof
  • Polymer systems are well-known in the art and non-limiting examples of these include aminoplast capsules and encapsulated particles as disclosed in Application GB 2006709 A; the production of micro-capsules having walls comprising styrene-maleic anhydride reacted with melamine-formaldehyde precondensates as disclosed in U.S. Pat. No. 4,396,670; an acrylic acid-acrylamide copolymer, cross-linked with a melamine-formaldehyde resin as disclosed in U.S. Pat. No. 5,089,339; capsules composed of cationic melamine-formaldehyde condensates as disclosed in U.S. Pat. No.
  • capsule wall material formed from a complex of cationic and anionic melamine-formaldehyde precondensates that are then cross-linked as disclosed in U.S. Pat. No. 5,013,473; polymeric shells made from addition polymers such as condensation polymers, phenolic aldehydes, urea aldehydes or acrylic polymers as disclosed in U.S. Pat. No.
  • Urea-formaldehyde and melamine-formaldehyde pre-condensate microcapsule shell wall precursors are prepared by means of reacting urea or melamine with formaldehyde where the mole ratio of melamine or urea to formaldehyde is in the range of from about 10:1 to about 1:6, preferably from about 1:2 to about 1:5.
  • the resulting material has a molecular weight in the range of from 156 to 3000.
  • the resulting material may be used ‘as-is’ as a cross-linking agent for the aforementioned substituted or un-substituted acrylic acid polymer or copolymer or it may be further reacted with a C 1 -C 6 alcohol, e.g., methanol, ethanol, 2-propanol, 3-propanol, 1-butanol, 1-pentanol or 1-hexanol, thereby forming a partial ether where the mole ratio of melamine/urea:formaldehyde:alcohol is in the range of 1:(0.1-6):(0.1-6).
  • a C 1 -C 6 alcohol e.g., methanol, ethanol, 2-propanol, 3-propanol, 1-butanol, 1-pentanol or 1-hexanol
  • the resulting ether moiety-containing product may be used ‘as-is’ as a cross-linking agent for the aforementioned substituted or un-substituted acrylic acid polymer or copolymer, or it may be self-condensed to form dimers, trimers and/or tetramers which may also be used as cross-linking agents for the aforementioned substituted or un-substituted acrylic acid polymers or co-polymers.
  • Methods for formation of such melamine-formaldehyde and urea-formaldehyde pre-condensates are set forth in U.S. Pat. Nos. 3,516,846 and 6,261,483, and Lee et al. (2002) J. Microencapsulation 19, 559-569.
  • Examples of urea-formaldehyde pre-condensates useful in the practice of this invention are URAC 180 and URAC 186, trademarks of Cytec Technology Corp. of Wilmington, Del.
  • Examples of melamine-formaldehyde pre-condensates useful in the practice if this invention include, but are not limited to, CYMEL U-60, CYMEL U-64 and CYMEL U-65, trademarks of Cytec Technology Corp. of Wilmington, Del. It is preferable to use, as the precondensate for cross-linking, the substituted or un-substituted acrylic acid polymer or co-polymer.
  • the range of mole ratios of urea-formaldehyde precondensate/melamine-formaldehyde pre-condensate to substituted/un-substituted acrylic acid polymer/co-polymer is in the range of from about 9:1 to about 1:9, preferably from about 5:1 to about 1:5 and most preferably from about 2:1 to about 1:2.
  • microcapsules with polymer(s) composed of primary and/or secondary amine reactive groups or mixtures thereof and cross-linkers can also be used.
  • the amine polymers can possess primary and/or secondary amine functionalities and can be of either natural or synthetic origin.
  • Amine-containing polymers of natural origin are typically proteins such as gelatin and albumen, as well as some polysaccharides.
  • Synthetic amine polymers include various degrees of hydrolyzed polyvinyl formamides, polyvinylamines, polyallyl amines and other synthetic polymers with primary and secondary amine pendants. Examples of suitable amine polymers are the LUPAMIN series of polyvinyl formamides available from BASF. The molecular weights of these materials can range from 10,000 to 1,000,000 Daltons.
  • Urea-formaldehyde or melamine-formaldehyde capsules can also include formaldehyde scavengers, which are capable of binding free formaldehyde.
  • formaldehyde scavengers such as sodium sulfite, melamine, glycine, and carbohydrazine are suitable.
  • formaldehyde scavengers are preferably selected from beta diketones, such as beta-ketoesters, or from 1,3-diols, such as propylene glycol.
  • beta-ketoesters include alkyl-malonates, alkyl aceto acetates and polyvinyl alcohol aceto acetates.
  • Sol-gel microcapsules each have a sol-gel polymer as the encapsulating polymer.
  • the sol-gel polymer is the polymerization product of a sol-gel precursor, a compound capable of forming a sol-gel polymer.
  • the sol-gel precursors are typically those containing silicon, boron, aluminum, titanium, zinc, zirconium, and vanadium.
  • Preferred precursors are organosilicon, organoboron, organoaluminum including metal alkoxides and b-diketonates, and combinations thereof.
  • Sol-gel precursors suitable for the purposes of the invention are selected in particular from the group of di-, tri- and/or tetrafunctional silicic acids (including derivatives such as silicates), boric acids (including derivatives such as esters), and alumoesters, more particularly alkoxysilanes (alkyl orthosilicates), and precursors thereof.
  • sol-gel precursors suitable for the purposes of the invention are compounds corresponding to the following general formula:
  • X can be hydrogen, —OR 3 , or R 4 ;
  • X′ can be hydrogen, —OR 5 , or R 6 ; and each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 independently represent an organic group, more particularly a linear or branched alkyl group, preferably a C 1 -C 12 alkyl.
  • M can be Si, Ti, or Zr.
  • a preferred sol/gel precursor is alkoxysilanes corresponding to the following general formula: (R 1 O)(R 2 O)Si(X)(X′), wherein each of X, X′, R 1 , and R 2 are defined above.
  • Particularly preferred compounds are the silicic acid esters such as tetramethyl orthosilicate (TMOS) and tetraethyl orthosilicate (TEOS).
  • TMOS tetramethyl orthosilicate
  • TEOS tetraethyl orthosilicate
  • a preferred compound includes Dynasylan® (organofunctional silanes commercially available from Degussa Corporation, Parsippany N.J., USA).
  • Other sol-gel precursors suitable for the purposes of the invention are described, for example, in German Patent Application DE10021165. These sol-gel precursors are various hydrolyzable organosilanes such as, for example, alkylsilanes, alkoxysilanes, alkyl alkoxysilanes and organoalkoxysilanes.
  • other organic groups for example allyl groups, aminoalkyl groups, hydroxyalkyl groups, etc. may be attached as substituents to the silicon.
  • metal and semi metal alkoxide monomers such as tetramethoxy silane (TMOS), tetraethoxy silane (TEOS), etc. are very good solvents for numerous molecules and active ingredients is highly advantageous since it facilitates dissolving the active materials at a high concentration and thus a high loading in the final capsules.
  • TMOS tetramethoxy silane
  • TEOS tetraethoxy silane
  • sol-gel precursors are partially crosslinked silica, which is an oligomeric or polymeric silica having one or more (e.g., two or more) silicic acid functional groups such as silicic acid esters and alkoxysilane groups. Having these silicic acid functional groups, the partially crosslinked silica is capable of polymerizing with another sol-gel precursor and/or another partially crosslinked silica to form a sol-gel polymer, the microcapsule wall material that encapsulates an active material.
  • silicic acid functional groups such as silicic acid esters and alkoxysilane groups.
  • the partially crosslinked silica typically has a molecular weight less than 20,000 Da (e.g., 1,000 to 10,000 Da, 1,500 to 5,000 Da, and 2,000 to 3,500 Da).
  • the partially crosslinked silica can be prepared using an alkoxysilane described above.
  • the alkoxysilane is polymerized to form oligomeric or polymeric silica having a molecular weight less than 20,000 Da.
  • These partially crosslinked silica can then further polymerized to form a much larger sol-gel polymer to encapsulate an active material.
  • Hydrogel microcapsules are prepared using a polymerizable material such as a monofunctional or multifunctional acrylic or methacrylic acid, or ester thereof. See e.g., WO2014/011860. Exemplary materials useful for preparing hydrogel microcapsules are listed below.
  • Preferred bi- or polyfunctional vinyl monomers include by way of illustration and not limitation, acrylic acid, methacrylic acid, 2-hydroxyethyl acrylate, methyl acrylate, ethyl acrylate, propyl acrylate, n-butyl acrylate, pentyl acrylate, hexyl acrylate, 2-ethylhexyl acrylate, heptyl acrylate, octyl acrylate, nonyl acrylate, decyl acrylate, dodecyl acrylate, tetradecyl acrylate, hexadecyl acrylate, isopropyl acrylate, isobutyl acrylate, sec-butyl acrylate, 2-ethylbutyl acrylate, 3-methylbutyl acrylate, 1-ethylpropyl acrylate, 2-methylpentyl acrylate, 2-ethylbutyl acrylate, 1,3-dimethyl
  • ester monomers of methacrylic acid which can be used include 2-hydrox ethyl methacrylate, glycidyl methacrylate, methyl methacrylate, ethyl methacrylate, n-propyl methacrylate, isopropyl methacrylate, n-butyl methacrylate, isobutyl methacrylate, sec-butyl methacrylate, tert-butyl methacrylate, n-hexyl methacrylate, n-octyl methacrylate, isooctyl methacrylate, decyl methacrylate, n-dodecyl methacrylate, n-tetradecyl methacrylate, n-hexadecyl methacrylate, 2-ethylhexyl methacrylate, allyl methacrylate, oleyl methacrylate, 2-propynyl methacrylate, 2-
  • the above monomers may be employed separately or in various mixtures.
  • the use of multifunctional acrylate and methacrylate will lead to the formation of cross-linked network polymers upon polymerization.
  • Such polymers have desirable properties such as good mechanical strength, elasticity, toughness, and flexibility.
  • Examples of multifunctional acrylates and methacrylates of use in this invention include, but are not limited to, ethylene glycol dimethacrylate (EGDMA), trimethylolpropane trimethacrylate, trimethyloyl triacrylate, pentaerythritol triacrylate, pentaerythritol tetracrylate, bisphenol A dimethacrylate, di (trimethylolpropane) tetraacrylate (DTTA), 1-(acryloyloxy)-3-(methacryloyloxy)-2-propanol (AOOP), trimethylolpropane ethoxylate triacrylate (TPETA), dipentaerythritol pentaacrylate, hexane diacrylate, poly (ethylene glycol) dimethacrylate (PEGDMA), and 1,6-hexandiol dimethacrylate (HDDMA), 1,4-butandiol dimethacrylate, 1,3-butandiol dimethacrylate
  • the acrylic or methacrylic acid, or ester thereof makes up less than 25% by mass, preferably 5 to 20% by mass, or more preferably 10 to 15% by mass of the oil phase.
  • Initiators are often used to start the polymerization reactions. Examples include but not limited to: AIBN, sodium persulfate, benzoyl peroxide.
  • Proteins useful in coacervation processes include albumins, vegetable globulins and gelatines.
  • the gelatine may be fish, pork, beef, and/or poultry gelatine, for example.
  • the protein is fish, beef or poultry gelatine.
  • the protein is warm water fish gelatine.
  • Typical non-protein polymers useful in complex coacervation methods include, in particular, negatively charged polymers.
  • they may be selected from gum arabic, xanthan, agar, alginate salts, cellulose derivatives, for example carboxymethyl cellulose, pectinate salts, carrageenan, polyacrylic and methacrylic acid, and/or mixtures thereof.
  • Further suitable non-proteins can be derived from the literature, for example from to WO 2004/022221.
  • a cross-linking agent is typically used to harden the coating layer.
  • Suitable cross-linking agents include formaldehyde, acetaldehyde, glutaraldehyde, glyoxal, chrome alum, or transglutaminase.
  • transglutaminase is used at 10-100, preferably 30-60 activity units per gram of gelatine. This enzyme is well described and commercially obtainable.
  • microcapsule formation aids are used as dispersants (namely, emulsifiers or surfactants). They facilitate the formation of stable emulsions containing nano- or micro-sized oil drops to be encapsulated. Further, microcapsule formation aids improve the performance of the microcapsule by stabilizing capsules and/or their deposition to the target areas or releasing to the environment. Performance is measured by the intensity of the fragrance release during the use experience, such as the pre-rub and post-rub phases in a laundry experience.
  • the pre-rub phase is the phase when the microcapsules have been deposited on the cloth, e.g., after a fabric softener containing microcapsules has been used during the wash cycle.
  • the post-rub phase is after the microcapsules have been deposited and the microcapsules are broken by friction or other similar mechanisms.
  • the amount of these microcapsule formation aids is anywhere from about 0.1 to about 40 percent by weight of the microcapsule, more preferably from 0.5 to about 10 percent, more preferably 0.5 to 5 percent by weigh.
  • Preferred microcapsule formation aids are polyvinyl pyrrolidone, polyvinyl alcohol, poly(styrene sulfonate), carboxymethyl cellulose, sodium salt of naphthalene sulfonate condensate, co-polymer of ethylene and maleic anhydride, an alginate, hyaluronic acid, poly(acrylic acid), carboxymethylcellulose, copolymers of acrylic acid and acrylamide, copolymer of acrylamide and acrylamidopropyltrimonium chloride, terpolymers of (acrylic acid, acrylamide, and acrylamidopropyltrimonium chloride), partially or completely hydrolyzed polyvinyl acetate polymers (i.e., polyvinyl alcohol), and combinations thereof.
  • microcapsule formation aids include water-soluble salts of alkyl sulfates, alkyl ether sulfates, alkyl isothionates, alkyl carboxylates, alkyl sulfosuccinates, alkyl succinamates, alkyl sulfate salts such as sodium dodecyl sulfate, alkyl sarcosinates, alkyl derivatives of protein hydrolyzates, acyl aspartates, alkyl or alkyl ether or alkylaryl ether phosphate esters, sodium dodecyl sulphate, phospholipids or lecithin, or soaps, sodium, potassium or ammonium stearate, oleate or palmitate, alkylarylsulfonic acid salts such as sodium dodecylbenzenesulfonate, sodium dialkylsulfosuccinates, dioctyl sulfosuccinate, sodium dilauryl
  • surfactants include, but are not limited to, sulfonated naphthalene-formaldehyde condensates such as MORWET D425 (naphthalene sulfonate, Akzo Nobel, Fort Worth, Tex.); partially hydrolyzed polyvinyl alcohols such as MOWIOLs, e.g., MOWIOL 3-83 (Air Products); ethylene oxide-propylene oxide block copolymers or poloxamers such as PLURONIC, SYNPERONIC or PLURACARE materials (BASF); sulfonated polystyrenes such as FLEXAN II (Akzo Nobel); ethylene-maleic anhydride polymers such as ZEMAC (Vertellus Specialties Inc.); copolymer of acrylamide and acrylamidopropyltrimonium chloride such as Salcare SC 60 (BASF); and Polyquaternium series such as Polyquaternium 11 (“PQ11;” a copolymer of vinyl sul
  • the capsule formation aid is a processing aid such as hydrocolloids, which improve the colloidal stability of the slurry against coagulation, sedimentation and creaming.
  • hydrocolloid refers to a broad class of water-soluble or water-dispersible polymers having anionic, cationic, zwitterionic or non-ionic character.
  • Hydrocolloids useful in the present invention include, but are not limited to, polycarbohydrates, such as starch, modified starch, dextrin, maltodextrin, and cellulose derivatives, and their quaternized forms; natural gums such as alginate esters, carrageenan, xanthanes, agar-agar, pectines, pectic acid, and natural gums such as gum arabic, gum tragacanth and gum karaya, guar gums and quaternized guar gums; gelatine, protein hydrolysates and their quaternized forms; synthetic polymers and copolymers, such as poly(vinyl pyrrolidone-co-vinyl acetate), poly(vinyl alcohol-co-vinyl acetate), poly((met)acrylic acid), poly(maleic acid), poly(alkyl(meth)acrylate-co-(meth)acrylic acid), poly(acrylic acid-co-maleic acid)copo
  • the capsule formation aid may also be used in combination with carboxymethyl cellulose (“CMC”), polyvinylpyrrolidone, polyvinyl alcohol, sodium polystyrene sulfonate, alkylnaphthalenesulfonate formaldehyde condensates, and/or a surfactant during processing to facilitate capsule formation.
  • CMC carboxymethyl cellulose
  • polyvinylpyrrolidone polyvinyl alcohol
  • sodium polystyrene sulfonate polyvinyl alcohol
  • alkylnaphthalenesulfonate formaldehyde condensates and/or a surfactant during processing to facilitate capsule formation.
  • CMC polymer has a molecular weight range between about 90,000 Daltons to 1,500,000 Daltons, preferably between about 250,000 Daltons to 750,000 Daltons and more preferably between 400,000 Daltons to 750,000 Daltons.
  • the CMC polymer has a degree of substitution between about 0.1 to about 3, preferably between about 0.65 to about 1.4, and more preferably between about 0.8 to about 1.0.
  • the CMC polymer is present in the capsule slurry at a level from about 0.1% to about 2% and preferably from about 0.3% to about 0.7%.
  • polyvinylpyrrolidone used in this invention is a water-soluble polymer and has a molecular weight of 1,000 to 10,000,000.
  • Suitable polyvinylpyrrolidone are polyvinylpyrrolidone K12, K15, K17, K25, K30, K60, K90, or a mixture thereof.
  • the amount of polyvinylpyrrolidone is 2-50%, 5-30%, or 10-25% by weight of the capsule delivery system.
  • Commercially available alkylnaphthalenesulfonate formaldehyde condensates include MORWET D-425, which is a sodium salt of naphthalene sulfonate condensate by Akzo Nobel, Fort Worth, Tex.
  • food-grade dispersants are use.
  • food-grade dispersant refers to a dispersant having a quality as fit for human consumption in food. They can be natural or non-natural products.
  • a natural product or surfactant refers to a product that is naturally occurring and comes from a nature source. Natural products/surfactants include their derivatives which can be salted, desalted, deoiled, fractionated, or modified using a natural enzyme or microorganism.
  • a non-natural surfactant is a chemically synthesized surfactant by a chemical process that does not involve an enzymatic modification.
  • Natural dispersants include quillaja saponin, lecithins, gum arabic, pectin, carrageenan, chitosan, chondroitin sulfate, cellulose gum, modified starch, whey protein, pea protein, egg white protein, silk protein, gelatin of fish, proteins of porcine or bovine origin, ester gum, fatty acids, and combinations thereof.
  • Non-natural dispersants include N-lauroyl-L-arginine ethyl ester, sorbitan esters, polyethoxylated sorbitan esters, polyglyceryl esters, fatty acid esters, and combination thereof.
  • Other food safe dispersant can also be included in the microcapsule of this invention.
  • examples include ammonium phosphatides, acetic acid esters of mono- and diglycerides (Acetem), lactic acid esters of mono- and diglycerides of fatty acids (Lactem), citric acid esters of mono and diglycerides of fatty acids (Citrem), mono and diacetyl tartaric acid esters of mono and diglycerides of fatty acids (Datem), succinic acid esters of monoglycerides of fatty acids (SMG), ethoxylated monoglycerides, sucrose esters of fatty acids, sucroglycerides, polyglycerol polyricinoleate, propane-1,2-diol esters of fatty acids, thermally oxidized soya bean oil interacted with mono- or diglycerides of fatty acids, sodium stearoyl lactylate (SSL), calcium stearoyl lactylate (CSL), stearyl tart
  • the Encapsulating polymer can also include one or more additional wall polymers, e.g., a second, third, fourth, fifth, or sixth polymer.
  • additional polymers can be selected from the group consisting of silica, polyacrylate, polyacrylamide, poly(acrylate-co-acrylamide), polyurea, polyurethane, starch, gelatin and gum Arabic, poly(melamine-formaldehyde), poly(urea-formaldehyde), and combinations thereof
  • an oil-in-water emulsion is first prepared containing (i) a polyamine, a polyalcohol, or mixture thereof, (ii) a polyisocyanate, carbonyl crosslinker, or mixture thereof, (iii) an oil phase having a hydrophilic core solvent and a hydrophobic core solvent, and (iv) an aqueous phase having a microcapsule formation aid and water.
  • the reaction between the polyamine/polyalcohol and the polyisocyanate/carbonyl crosslinker occurs when the temperature of the reaction mixture is raised or a catalyst (such as a transglutaminase for catalyzing amide formation) is added to the mixture.
  • a catalyst such as a transglutaminase for catalyzing amide formation
  • Catalysts suitable for use in the polyurea/polyurethane formation are transglutaminases, metal carbonates, metal hydroxide, amino or organometallic compounds and include, for example, sodium carbonate, cesium carbonate, potassium carbonate, lithium hydroxide, 1,4-diazabicyclo[2.2.2]octane (i.e., DABCO), N,N-dimethylaminoethanol, N,N-dimethylcyclohexylamine, bis-(2-dimethylamino-ethyl) ether, N,N dimethylacetylamine, stannous octoate and dibutyltin dilaurate.
  • transglutaminases include, for example, sodium carbonate, cesium carbonate, potassium carbonate, lithium hydroxide, 1,4-diazabicyclo[2.2.2]octane (i.e., DABCO), N,N-dimethylaminoethanol, N,N-dimethylcycl
  • the resultant microcapsule slurry is then cured at a predetermined temperature for a predetermined period of time.
  • the microcapsules prepared according to the methods above are cured at a temperature in the range of, e.g., 15° C. to 230° C. (e.g., 55° C. to 90° C., 55° C. to 75° C., and 90° C. to 130° C.) for 1 minute to 10 hours (e.g., 0.1 hours to 5 hours, 0.2 hours to 4 hours and 0.5 hours to 3 hours).
  • a skilled person in the art can determine, without undue experiments, the curing temperature, duration, and the heating rate.
  • certain embodiments of this invention provide for a cure at a low temperature, e.g., less than 100° C.
  • the cure temperature is at or less than 90° C. In other embodiments, the cure temperature is at or less than 80° C.
  • the capsules are heated to a target cure temperature at a linear rate of 0.5 to 2° C. per minute (e.g., 1 to 5° C. per minute, 2 to 8° C. per minute, and 2 to 10° C. per minute) over a period of 1 to 60 minutes (e.g., 1 to 30 minutes).
  • the following heating methods may be used: conduction for example via oil, steam radiation via infrared, and microwave, convection via heated air, steam injection and other methods known by those skilled in the art.
  • the target cure temperature used herein refers to the minimum temperature in degrees Celsius at which the capsules may be cured to retard leaching.
  • microcapsule compositions of the invention have one or more active materials in the external hydrophilic solvent.
  • active materials include those described in WO2015/023961.
  • microcapsule compositions can also include the following active materials:
  • taste masking agents substances for masking one or more unpleasant taste sensations, in particular a bitter, astringent and/or metallic taste sensation or aftertaste.
  • Examples include lactisol [2O-(4-methoxyphenyl) lactic acid] (cf. U.S. Pat. No. 5,045,336), 2,4-dihydroxybenzoic acid potassium salt (cf. U.S. Pat. No. 5,643,941), ginger extracts (cf. GB 2,380,936), neohesperidine dihydrochalcone (cf. Manufacturing Chemist 2000, July issue, p. 16-17), specific flavones (2-phenylchrom-2-en-4-ones) (cf. U.S. Pat.
  • nucleotides for example cytidine-5′-monophosphates (CMP) (cf. US 2002/0177576), specific sodium salts, such as sodium chloride, sodium citrate, sodium acetate and sodium lactate (cf. Nature, 1997, Vol. 387, p. 563), a lipoprotein of .beta.-lactoglobulin and phosphatidic acid (cf. EPA 635 218), neodiosmine [5,7-dihydroxy-2-(4-methoxy-3-hydroxyphenyl)-7-O-neohesperidosyl-chrom-2-en-4-one] (cf. U.S. Pat. No.
  • hydroxyflavanones according to EP 1 258 200, in turn preferred in this respect 2-(4-hydroxyphenyl)-5,7-dihydroxychroman-4-one (naringenin), 2-(3,4-dihydroxyphenyl)-5,7-dihydroxychroman-4-one (eriodictyol), 2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxychroman-4-one (eriodictyol-7-methylether), 2-(3,4-dihydroxyphenyl)-7-hydroxy-5-methoxychroman-4-one (eriodictyol-5-methylether) and 2-(4-hydroxy-3-methoxyphenyl)-5,7-dihydroxychroman-4-one (homoeriodictyol), the (2S)— or (2R)-enantiomers thereof or mixtures thereof as well as the mono- or polyvalent phenolate salts thereof with Na + , K + , NH4 + , Ca 2
  • taste sensates including hot tasting, salivation-inducing substances, substances causing a warmth or tingling feeling, and cooling active ingredients.
  • hot tasting and/or salivation-inducing substances and/or substances which cause a feeling of warmth and/or a tingling feeling on the skin or on the mucous membranes and which can be a constituent of the products according to the invention are: capsaicin, dihydrocapsaicin, gingerol, paradol, shogaol, piperine, carboxylic acid-N-vanillylamides, in particular nonanoic acid-N-vanillylamide, pellitorin or spilanthol, 2-nonanoic acid amides, in particular 2-nonanoic acid-N-isobutylamide, 2-nonanoic acid-N-4-hydroxy-3-methoxyphenylamide, alkyl ethers of 4-hydroxy-3-methoxybenzyl alcohol, in particular 4-hydroxy-3-methoxybenzyl-n-but
  • Examples of preferred hot tasting natural extracts and/or natural extracts which cause a feeling of warmth and/or a tingling feeling on the skin or on the mucous membranes and which can be a constituent of the products according to the invention are: extracts of paprika, extracts of pepper (for example capsicum extract), extracts of chili pepper, extracts of ginger roots, extracts of Aframomum melgueta , extracts of s, extracts of Kaempferia galangal or extracts of Alpinia galanga .
  • Suitable cooling active ingredients include the following: 1-menthol, d-menthol, racemic menthol, menthone glycerol acetal (trade name: Frescolat®MGA), menthyl lactate (trade name: Frescolat®ML, menthyl lactate preferably being 1-menthyl lactate, in particular 1-menthyl-1-lactate), substituted menthyl-3-carboxamides (for example menthyl-3-carboxylic acid-N-ethylamide), 2-isopropyl-N-2,3-trimethyl-butanamide, substituted cyclohexane carboxamides, 3-menthoxypropane-1,2-diol, 2-hydroxyethyl menthyl carbonate, 2-hydroxypropyl menthyl carbonate, N-acetylglycine menthyl ester, isopulegol, hydroxycarboxylic acid menthyl esters (for example menthyl-3-hydroxybutyrate), monomenth
  • Cooling active ingredients which are particularly preferred are as follows: 1-menthol, racemic menthol, menthone glycerol acetal (trade name: Frescolat®MGA), menthyl lactate (preferably 1-menthyl lactate, in particular 1-menthyl-1-lactate, trade name: Frescolat®ML), 3-menthoxypropane-1,2-diol, 2-hydroxyethyl menthyl carbonate, 2-hydroxypropyl menthyl carbonate.
  • malodor counteracting agents including an ⁇ , ⁇ -unsaturated carbonyl compounds including but not limited to those disclosed in U.S. Pat. No. 6,610,648 and EP 2,524,704, amyl cinnamaldehyde, benzophenone, benzyl benzoate, benzyl isoeugenol, benzyl phenyl acetate, benzyl salicylate, butyl cinnamate, cinnamyl butyrate, cinnamyl isovalerate, cinnamyl propionate, decyl acetate, ethyl myristate, isobutyl cinnamate, isoamyl salicylate, phenethyl benzoate, phenethyl phenyl acetate, triethyl citrate, tripropylene glycol n-butyl ether, isomers of bicyclo[2.2.1]hept-5-ene-2
  • They may include mixture of hexahydro-4,7-methanoinden-5-yl propionate and hexahydro-4,7-methanoinden-6-yl propionate; 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-methyl-3-buten-2-one; 3,7-dimethyl-2,6-nonadien-1-nitrile; dodecahydro-3a,6,6,9a-tetramethylnaphtho(2,1-b)furan; ethylene glycol cyclic ester of n-dodecanedioic acid; 1-cyclohexadecen-6-one; 1-cycloheptadecen-10-one; and corn mint oil.
  • They may also include 1-cyclohexylethan-1-yl butyrate; 1-cyclohexylethan-1-yl acetate; 1-cyclohexylethan-1-ol; 1-(4′-methylethyl)cyclohexylethan-1-yl propionate; and 2′-hydroxy-1′-ethyl(2-phenoxy)acetate each of which compound is marketed under the trademark VEILEX by International Flavors & Fragrances Inc.
  • More suitable malodor counteracting agents are polymers containing an ⁇ -keto, benzaldehyde, or ⁇ , ⁇ -unsaturated carbonyl moiety, such as those described in US Application Publications 2012/0294821, 2013/0101544 and 2013/0101545;
  • vitamins including any vitamin, a derivative thereof and a salt thereof examples are as follows: vitamin A and its analogs and derivatives (e.g., retinol, retinal, retinyl palmitate, retinoic acid, tretinoin, and iso-tretinoin, known collectively as retinoids), vitamin E (tocopherol and its derivatives), vitamin C (L-ascorbic acid and its esters and other derivatives), vitamin B3 (niacinamide and its derivatives), alpha hydroxy acids (such as glycolic acid, lactic acid, tartaric acid, malic acid, citric acid, etc.) and beta hydroxy acids (such as salicylic acid and the like);
  • vitamin A and its analogs and derivatives e.g., retinol, retinal, retinyl palmitate, retinoic acid, tretinoin, and iso-tretinoin, known collectively as retinoids
  • vitamin E tocopherol and its derivatives
  • vitamin C L
  • antibacterials including bisguanidines (e.g., chlorhexidine digluconate), diphenyl compounds, benzyl alcohols, trihalocarbanilides, quaternary ammonium compounds, ethoxylated phenols, and phenolic compounds, such as halo-substituted phenolic compounds, like PCMX (i.e., p-chloro-m-xylenol), triclosan (i.e., 2, 4, 4 ‘-trichloro-2’ hydroxy-diphenylether), thymol, and triclocarban;
  • bisguanidines e.g., chlorhexidine digluconate
  • diphenyl compounds e.g., benzyl alcohols, trihalocarbanilides, quaternary ammonium compounds, ethoxylated phenols, and phenolic compounds, such as halo-substituted phenolic compounds, like PCMX (i.e.,
  • sunscreen actives including oxybenzone, octylmethoxy cinnamate, butylmethoxy dibenzoyln ethane, p-aminobenzoic acid and octyl dimethyl-p-aminobenzoic acid;
  • antioxidants such as beta-carotene, vitamin C (Ascorbic Acid) or an ester thereof, vitamin A or an ester thereof, vitamin E or an ester thereof, lutein or an ester thereof, lignan, lycopene, selenium, flavonoids, vitamin-like antioxidants such as coenzyme Q10 (CoQ10) and glutathione, and antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase;
  • SOD superoxide dismutase
  • anti-inflammatory agents including, e.g., methyl salicylate, aspirin, ibuprofen, and naproxen.
  • Additional anti-inflammatories useful in topical applications include corticosteroids, such as, but not limited to, flurandrenolide, clobetasol propionate, halobetasol propionate, fluticasone propionate, betamethasone dipropionate, betamethasone benzoate, betamethasone valerate, desoximethasone, dexamethasone, diflorasone diacetate, mometasone furoate, amcinodine, halcinonide, fluocinonide, fluocinolone acetonide, desonide, triamcinolone acetonide, hydrocortisone, hydrocortisone acetate, fluoromethalone, methylprednisolone, and predinicarbate;
  • corticosteroids such as, but not limited to,
  • anesthetics that can be delivered locally including benzocaine, butamben, butamben picrate, cocaine, procaine, tetracaine, lidocaine and pramoxine hydrochloride;
  • analgesics such as ibuprofen, diclofenac, capsaicin, and lidocaine;
  • Non-limiting examples are micanazole, clotrimazole, butoconazole, fenticonasole, tioconazole, terconazole, sulconazole, fluconazole, haloprogin, ketonazole, ketoconazole, oxinazole, econazole, itraconazole, torbinafine, nystatin and griseofulvin;
  • antibiotics such as erythromycin, clindamycin, synthomycin, tetracycline, metronidazole and the like;
  • anti-viral agents including famcyclovir, valacyclovir and acyclovir;
  • anti-parasitic agents such as scabicedes, such as permethrin, crotamiton, lindane and ivermectin;
  • anti-infectious and anti-acne agents including benzoyl peroxide, sulfur, resorcinol and salicylic acid;
  • dermatological active ingredients useful in topical applications including, e.g., jojoba oil and aromatic oils such as methyl salicylate, wintergreen, peppermint oil, bay oil, eucalyptus oil and citrus oils, as well as ammonium phenolsulfonate, bismuth subgallate, zinc phenolsulfonate and zinc salicylate;
  • enzymes and co-enzymes useful for topical application including co-enzyme Q10, papain enzyme, lipases, proteases, superoxide dismutase, fibrinolysin, desoxyribonuclease, trypsin, collagenase and sutilains;
  • (xix) anti-histamines including chlorpheniramine, brompheniramine, dexchlorpheniramine, tripolidine, clemastine, diphenhydramine, prometazine, piperazines, piperidines, astemizole, loratadine and terfonadine;
  • chemotherapeutic agents such as 5-fluorouracil, masoprocol, mechlorethamine, cyclophosphamide, vincristine, chlorambucil, streptozocin, methotrexate, bleomycin, dactinomycin, daunorubicin, coxorubicin and tamoxifen;
  • taste modulators including sweetness enhancer such as positive allosteric modulators (PAMs), bitterness inhibitors, saltiness enhancers, sourness inhibitors, and umami enhancers.
  • Active materials also include flavor enhancer, taste modulators and artificial sweeteners.
  • Exemplary sweetener and sweet modulators are rebaudioside C; plant extracts and derivatives, e.g., transglucosylated R. suavissimus extract; naringenin and salts; positive allosteric modulators (“PAMs”) such as sulfamide compounds. See WO 2013/096290; US 2015/0305380; US 2015/0272184; and WO 2015/199987.
  • Exemplary salt taste modulators include apsaicin; resiniferatoxin (RTX); piperine; 2-(3,4-dimethylbenzyl)-3- ⁇ [(4-hydroxy-3-methoxybenzyl)amino]carbothioyl ⁇ propyl pivalate (agonist 23); olvanil, capsiate; evodiamine; ethanol; cetylpyridinium chloride; dodecylpyridinium bromide; capsazepin; SB366791, etc. See WO 2005/006/881;
  • sweeteners such as steviol glycosides (Stevioside, Rebaudioside A, Rebaudioside C, Dulcoside A, Rebaudioside B, Rebaudioside D, Rebaudioside E, rubusoside, and combinations thereof), carbohydrate sweetener (sucrose, lactose, trehalose, glucose, fructose, sorbitol, mannitol, lactitol, xylitol, inulin, oligofructose, fructooligosaccharides, corn syrup, fruit juice concentrate, honey, malt, rice syrup, molasses, and agave syrup), and other artificial sweeteners (aspartame, sucralose, neotame, acesulfame potassium (Ace-K), saccharin, and advantame);
  • steviol glycosides Stevioside, Rebaudioside A, Rebaudioside C, Dulcoside A, Rebaudioside B, Rebaudioside D, Rebaudioside E,
  • probiotics namely live microorganisms which, when administered in effective amounts, confer a beneficial physiological effect on the host.
  • examples include L. bulgaricus, S. thermophiles, B. bifidum, L. lactis spp. Lactis, B. infantis, B. longum, L. paracasei, L. acidophilus, B. lactis, L. casei, B. adolescentis, B. breve, L. rhamnosus , and other Lactobacillus and Bifidobacterium genera.
  • the products of this invention can also contain, for example, the following dyes, colorants or pigments: lactoflavin (riboflavin), beta-carotene, riboflavin-5′-phosphate, alpha-carotene, gamma-carotene, cantaxanthin, erythrosine, curcumin, quinoline yellow, yellow orange S, tartrazine, bixin, norbixin (annatto, orlean), capsanthin, capsorubin, lycopene, beta-apo-8′-carotenal, beta-apo-8′-carotenic acid ethyl ester, xantophylls (flavoxanthin, lutein, cryptoxanthin, rubixanthin, violaxanthin, rodoxanthin), fast carmine (carminic acid, cochineal), azorubin, cochineal red A (Ponceau 4 R), beetroot red, betanin, antho
  • extracts for example paprika extract, black carrot extract, red cabbage extract
  • so-called aluminum lakes FD & C Yellow 5 Lake, FD & C Blue 2 Lake, FD & C Blue 1 Lake, Tartrazine Lake, Quinoline Yellow Lake, FD & C Yellow 6 Lake, FD & C Red 40 Lake, Sunset Yellow Lake, Carmoisine Lake, Amaranth Lake, Ponceau 4R Lake, Erythrosyne Lake, Red 2G Lake, Allura Red Lake, Patent Blue V Lake, Indigo Carmine Lake, Brilliant Blue Lake, Brown HT Lake, Black PN Lake, Green S Lake and mixtures thereof.
  • the amount of active material in the microcapsule composition is from 0.1 to 95% (e.g., 1 to 90%, 2% to 80%, 4 to 70%, and 5 to 50%) by weight of the composition.
  • the amount of the capsule wall is from 10 to 98% (e.g., 20 to 95%, 30 to 90%, and 50 to 80%) by weight of the capsule.
  • the amount of the microcapsule core (the sum of the hydrophilic and hydrophobic core solvents) is from 2 to 90% (e.g., 5 to 80%, 10 to 70%, and 20 to 50%) by weight of the capsule.
  • the ratio between the capsule and active material is 4:1 to 40:1 (e.g., 5:1 to 30:1 and 6:1 to 20:1).
  • adjunct materials including emollients, and core modifier materials in the core encapsulated by the capsule wall.
  • Other adjunct materials are solubility modifiers, density modifiers, stabilizers, viscosity modifiers, pH modifiers, or any combination thereof.
  • These modifiers can be present in the wall or core of the capsules, or outside the capsules in the microcapsule compositions. Preferably, they are in the core as a core modifier.
  • the one or more adjunct material may be added in the amount of from 0.01% to 25% (e.g., from 0.5% to 10%) by weight of the capsule.
  • Emollients have the quality of softening or soothing the skin. They keep the skin moist and flexible, helping to prevent cracks. Commonly used emollients are described below.
  • Triglycerides and modified triglycerides as emollients include vegetable oils such as jojoba, soybean, canola, sunflower, safflower, rice bran, avocado, almond, olive, sesame, persic, castor, coconut, and mink oils.
  • Ester oils have at least one ester group in the molecule.
  • One type of common ester oil useful in the present invention are the fatty acid mono and polyesters such as cetyl octanoate, octyl isonanoanate, myristyl lactate, cetyl lactate, isopropyl myristate, myristyl myristate, isopropyl palmitate, isopropyl adipate, butyl stearate, decyl oleate, cholesterol isostearate, glycerol monostearate, glycerol distearate, glycerol tristearate, alkyl lactate, alkyl citrate and alkyl tartrate.
  • polyesters suitable for the present invention are the polyesters marketed by ExxonMobil under the trade name PURESYNTM ESTERS and Polyalphaolefins (PAO), hydrophobic plant extracts.
  • Silicones include, for example, linear and cyclic polydimethylsiloxanes, amino-modified, alkyl, aryl, and alkylaryl silicone oil.
  • Nanoscale solid particulate materials such as those disclosed in U.S. Pat. No. 7,833,960 may also be incorporated into the core and may be selected from, but not limited to, metal or metallic particles, metal alloys, polymer particles, wax particles, inorganic particulates, minerals and clay particles.
  • the metal particles can be selected from a non-limiting list of main group elements, transition metal and post-transition metal elements including aluminum (Al), silica (Si), Titanium (Ti), chromium (Cr), manganese (Mn), iron (Fe), nickel (Ni), cobalt (Co), copper (Cu), gold (Au), silver (Ag), platinum (Pt) and palladium (Pd).
  • transition metal and post-transition metal elements including aluminum (Al), silica (Si), Titanium (Ti), chromium (Cr), manganese (Mn), iron (Fe), nickel (Ni), cobalt (Co), copper (Cu), gold (Au), silver (Ag), platinum (Pt) and palladium (Pd).
  • Polymer particles of any chemical composition and nature are suitable for the present invention as long as their physical dimension falls into the prescribed region and a liquid core is generated.
  • the polymer particles can be selected from a nonlimiting list of polymers and co-copolymer based on polystyrene, polyvinyl acetate, polylactides, polyglycolides, ethylene maleic anhydride copolymer, polyethylene, polypropylene, polyamide, polyimide, polycarbonate, polyester, polyurethane, polyurea, cellulose and cellulose, and combinations and mixture of such polymers.
  • the inorganic particulate can be selected from a non-limiting list including silica, titanium dioxide (TiO2), zinc oxide (ZnO), Fe2O3, and other metal oxides such as but not limited to NiO, Al 2 O 3 , SnO, SnO2, CeO2, ZnO, CdO, RuO2, FeO, CuO, AgO, MnO2, as well as other transition metal oxides.
  • nanoscaled material examples include AEROSIL R812, which has a particle size of less than 25 nm according to the specification from the manufacture, Degussa Corp.
  • suitable materials from Degussa include, but not limited to, AEROSIL R972, AEROSIL R974, AEROSIL R104, AEROSIL R106, AEROSIL R202, AEROSIL R805, AEROSIL R812, AEROSIL R812S, AEROSIL R816, AEROSIL R7200, AEROSIL R9200, and AEROXIDE TiO2 P25, AEROXIDE T805, AEROXIDE LE1, AEROXIDE LE2, AEROXIDE TiO2 NKT 90, AEROXIDE Alu C805, titanium dioxide PF2, SIPERNAT D110, SIPERNAT D-380.
  • the hydrophobic materials from Deguassa Corp. such as including AEROSILE R812 and R972 are especially preferred.
  • Nanoscaled materials such as UVINUL TiO 2 and Z-COTE HP1 manufactured by BASF can also be used as well as and TI-PURE titanium dioxide, TI-PURE R-700, and TI-SELECT. Additional suitable materials include TS-6200 from Dupont and ZEROFREE 516, HUBERDERM 2000 and HUBERDERM 1000 from the J.M. Huber Corporation, Havre De Grace, Md. Silica products such as SYLOID 63, 244, 72, 63FP 244FP, 72FP, SYLOX 15, 2 and Zeolites such as SYLOSIV A3, SYLOSIV A4 and SYLOSIV K300 from Grace Davison can also be used.
  • Polymeric core modifiers are also contemplated. It has been found that the addition of hydrophobic polymers to the core can also improve stability by slowing diffusion of the fragrance from the core.
  • the level of polymer is normally less than 80% of the core by weight, preferably less than 50%, and most preferably less than 20%.
  • the basic requirement for the polymer is that it be miscible or compatible with the other components of the core, namely the fragrance and other solvent.
  • the polymer also thickens or gels the core, thus further reducing diffusion.
  • Polymeric core modifiers include copolymers of ethylene; copolymers of ethylene and vinyl acetate (ELVAX polymers by DOW Corporation); copolymers of ethylene and vinyl alcohol (EVAL polymers by Kuraray); ethylene/acrylic elastomers such as VALNAC polymers by Dupont; polyvinyl polymers, such as polyvinyl acetate; alkyl-substituted cellulose, such as ethyl cellulose (ETHOCEL made by DOW Corporation) and hydroxypropyl celluloses (KLUCEL polymers by Hercules); cellulose acetate butyrate available from Eastman Chemical; polyacrylates (e.g., AMPHOMER, DEMACRYL LT and DERMACRYL 79, made by National Starch and Chemical Company, the AMERHOLD polymers by Amerchol Corporation, and ACUDYNE 258 by ISP Corporation); copolymers of acrylic or methacrylic acid and fatty esters of acrylic or methacrylic acid such as
  • polymers include polyethylene oxide-co-propyleneoxide-co-butylene oxide polymers of any ethylene oxide/propylene oxide/butylene oxide ratio with cationic groups resulting in a net theoretical positive charge or equal to zero (amphoteric).
  • the general structure is:
  • R 1 , R 2 , R 3 , and R 4 are independently H or any alkyl or fatty alkyl chain group.
  • examples of such polymers are the commercially known as TETRONICS by BASF Corporation.
  • Nonlimiting examples of a solubility modifier include surfactants (e.g., SLS and Tween 80), acidic compounds (e.g., mineral acids such as sulfuric acid, hydrochloric acid, nitric acid, and phosphoric acid, and carboxylic acids such as acetic acid, citric acid, gluconic acid, glucoheptonic acid, and lactic acid), basic compounds (e.g., ammonia, alkali metal and alkaline earth metal hydroxides, primary, secondary, or tertiary amines, and primary, secondary, or tertiary alkanolamines), ethyl alcohol, glycerol, glucose, galactose, inositol, mannitol, glactitol, adonitol, arabitol, and amino acids.
  • surfactants e.g., SLS and Tween 80
  • acidic compounds e.g., mineral acids such as sulfuric acid, hydrochlor
  • the density of the capsule slurry and/or the oil core can be adjusted so that the capsule composition has a substantially uniform distribution of the capsules using known density modifiers or technologies such as those described in Patent Application Publications WO 2000/059616, EP 1 502 646, and EP 2 204 155.
  • Suitable density modifiers include hydrophobic materials and materials having a desired molecular weight (e.g., higher than about 12,000), such as silicone oils, petrolatums, vegetable oils, especially sunflower oil and rapeseed oil, and hydrophobic solvents having a desired density (e.g., less than about 1,000 Kg/m3 at 25° C., such as limonene and octane.
  • a stabilizer e.g., a colloidal stabilizer
  • colloidal stabilizers are polyvinyl alcohol, cellulose derivatives such hydroxyethyl cellulose, polyethylene oxide, copolymers of polyethylene oxide and polyethylene or polypropylene oxide, or copolymers of acrylamide and acrylic acid.
  • a stabilizing agent i.e., a stabilizer
  • a stabilizer is added to the capsule delivery system to improve the stability of the delivery system for an extended period of storage. When one of these delivery system is added to a consumer product such as a liquid fabric softener/freshener and liquid detergent, this delivery system will also improve the viscosity stability of the consumer product, thus extend the shelf life of the product.
  • Useful stabilizing agents include multi-functional amines, amino acids/peptides, monofunctional amines, polymers, and a polymeric mixture. These stabilizing agents are in presence in the compositions as free compounds, which are not covalently attached to the capsule walls, being part of the capsule walls, or encapsulated in capsules.
  • Multi-functional amines are those having at least an amine group (primary, secondary, or tertiary) and one or more other functional groups such as an amine and hydroxyl group.
  • Exemplary multi-functional amines include hexamethylenediamine, hexaethylenediamine, ethylenediamine, 1,3-diaminopropane, 1,4-diamino-butane, diethylenetriamine, pentaethylenehexamine, bis(3-aminopropyl)amine, bis(hexamethylene)triamine, tris(2-aminoethyl)amine, triethylene-tetramine, N,N′-bis(3-aminopropyl)-1,3-propanediamine, tetraethylenepentamine, amino-2-methyl-1-propanol branched polyethylenimine, chitosan, 1,3-diamino-guanidine, 1,1-dimethylbiguanide, and guanidine.
  • Suitable amino acids/peptides include arginine, lysine, histidine, ornithine, nisin, and gelatin.
  • Suitable stabilizing polymers include polyvinylpyrrolidone, polyvinylpyridine-N-oxide, and polyvinyl imidazolinium. These polymers sometimes are used in combination with a second polymer (e.g., a block copolymer) such that the second polymer.
  • Monofunational amines have a single amine group.
  • Examples include C1-C20 primary, secondary, or tertiary amines, each of which typically has a molecular weight of 30 to 800 Daltons (e.g., 31 to 500 Daltons and 31 to 300 Daltons). They can be linear, branched, cyclic, acyclic, saturated, unsaturated, aliphatic, and/or aromatic.
  • Nonlimiting examples are methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, propylamine, isopropylamine, butylamine, dodecylamine, tetradecylamine, aniline, 4-methylaniline, 2-nitroaniline, diphenyl amine, pyrrolidone, piperidine, and morpholine.
  • the stabilizing agent in the capsule composition can be present in an amount effective to stabilize the composition and/or the final consumer product containing the composition.
  • This amount can be 1 ppm or greater (e.g., 20 ppm or greater, 20 ppm to 20%, 50 ppm to 10%, 50 ppm to 2%, 50 ppm to 1%, 50 to 2000 ppm, and 50 to 1000 ppm).
  • Its concentration in a consumer product can be 20 ppm to 2% (e.g., 50 ppm to 2%, 50 ppm to 1%, 50 to 2000 ppm, and 50 to 1000 ppm).
  • humectants are optionally included to hold water in the capsule composition for a long period of time.
  • examples include glycerin, propylene glycol, alkyl phosphate esters, quaternary amines, inorganic salts (e.g., potassium polymetaphosphate, sodium chloride, etc.), polyethylene glycols, and the like.
  • humectants as well as viscosity control/suspending agents, are disclosed in U.S. Pat. Nos. 4,428,869, 4,464,271, 4,446,032, and 6,930,078.
  • hydrophobic silicas as a functional delivery vehicle of active materials other than a free flow/anticaking agent are disclosed in U.S. Pat. Nos. 5,500,223 and 6,608,017.
  • one or more pH modifiers are included in the capsule composition to adjust the pH value of the capsule slurry and/or the capsule cores.
  • the pH modifiers can also assist in the formation of capsule walls by changing the reaction rate of the crosslinking reactions that form the capsule walls.
  • Exemplary pH modifiers include metal hydroxides (e.g., LiOH, NaOH, KOH, and Mg(OH)2), metal carbonates and bicarbonates (CsCO3 Li2CO3, K2CO3, NaHCO 3 , and CaCO3), metal phosphates/hydrogen phosphates/dihydrogen phosphates, metal sulfates, ammonia, mineral acids (HCl, H2504, H3PO4, and HNO3), carboxylic acids (e.g., acetic acid, citric acid, lactic acid, benzoic acid, and sulfonic acids), and amino acids.
  • metal hydroxides e.g., LiOH, NaOH, KOH, and Mg(OH)2
  • metal phosphates/hydrogen phosphates/dihydrogen phosphates metal sulfates
  • ammonia HCl, H2504, H3PO4, and HNO
  • the level of the adjunct materials can be present at a level of 0.01 to 25% (e.g., from 0.5% to 10%) or greater than 10% (e.g., greater than 30% and greater than 70%).
  • a capsule deposition aid from 0.01 to 25%, more preferably from 5 to 20% can be included by weight of the capsule.
  • the capsule deposition aid can be added during the preparation of the capsules or it can be added after the capsules have been made.
  • deposition aids are used to aid in deposition of capsules to surfaces such as fabric, hair or skin.
  • These include anionically, cationically, nonionically, or amphoteric water-soluble polymers. Those skilled in the art would appreciate that the charge of these polymers can be adjusted by changing the pH, depending on the product in which this technology is to be used. Any suitable method for coating the deposition aids onto the encapsulated fragrance materials can be used.
  • suitable polymers for assisted capsule delivery to interfaces depends on the compatibility with the capsule wall chemistry since there has to be some association to the capsule wall.
  • This association can be through physical interactions, such as hydrogen bonding, ionic interactions, hydrophobic interactions, electron transfer interactions or, alternatively, the polymer coating could be chemically (covalently) grafted to the capsule or particle surface.
  • Chemical modification of the capsule or particle surface is another way to optimize anchoring of the polymer coating to capsule or particle surface.
  • the capsule and the polymer need to be compatible with the chemistry (polarity, for instance) of the desired interface.
  • the polymer can be selected from one or more polymers with an overall zero (amphoteric: mixture of cationic and anionic functional groups) or net positive charge, based on the following polymer backbones: polysaccharides, polypeptides, polycarbonates, polyesters, polyolefinic (vinyl, acrylic, acrylamide, poly diene), polyester, polyether, polyurethane, polyoxazoline, polyamine, silicone, polyphosphazine, olyaromatic, poly heterocyclic, or polyionene, with molecular weight (MW) ranging from about 1,000 to about 1000,000,000, preferably from about 5,000 to about 10,000,000. As used herein, molecular weight is provided as weight average molecular weight.
  • MW molecular weight
  • cationic reagents of choice are 3-chloro-2-hydroxypropyl trimethylammonium chloride or its epoxy version.
  • Another example is graft-copolymers of polyDADMAC on cellulose.
  • polysaccharides can be employed with aldehyde, carboxyl, succinate, acetate, alkyl, amide, sulfonate, ethoxy, propoxy, butoxy, and combinations of these functionalities; or any hydrophobic modification (compared to the polarity of the polysaccharide backbone).
  • the above modifications can be in any ratio and the degree of functionalization can be up to complete substitution of all functionalizable groups, as long as the theoretical net charge of the polymer is zero (mixture of cationic and anionic functional groups) or preferably positive.
  • up to 5 different types of functional groups may be attached to the polysaccharides.
  • polymer graft chains may be differently modified to the backbone.
  • the counterions can be any halide ion or organic counter ion. See U.S. Pat. Nos. 6,297,203 and 6,200,554.
  • Another source of cationic polymers contain protonatable amine groups so that the overall net charge is zero (amphoteric: mixture of cationic and anionic functional groups) or positive.
  • the pH during use will determine the overall net charge of the polymer. Examples include silk protein, zein, gelatin, keratin, collagen and any polypeptide, such as polylysine.
  • Further cationic polymers include polyvinyl polymers with up to 5 different types of monomers can be used.
  • the monomers of such polymer have the generic formula:
  • R 1 is H, C 1 -C 25 alkane, C 1 -C 25 alkene (in which the number of double bonds ranges from 1-5), C 1 -C 25 alkoxylated fatty alcohol, or a liquid crystalline moiety that can provide the polymer with thermotropic liquid crystalline properties;
  • R 2 is H or CH 3 ;
  • R 3 is —Cl, —NH 2 (i.e., polyvinyl amine or its copolymers with N-vinyl formamide.
  • Such polyvinyl polymers are sold under the name LUPAMIN 9095 by BASF Corporation. Further suitable cationic polymers containing hydroxylalkylvinylamine units, as disclosed in U.S. Pat. No. 6,057,404.
  • R 1 is H, C 1 -C 25 alkane, C 1 -C 25 alkene (in which the number of double bonds ranges from 1-5), C 1 -C 25 alkoxylated fatty alcohol, or a liquid crystalline moiety that can provide the polymer with thermotropic liquid crystalline properties;
  • R 2 is H or CH 3 ;
  • R 3 is a C 1 -C 25 alkyl alcohol or an alkylene oxide with any number of double bonds, or R 3 may be absent such that the C ⁇ O bond is (via the C-atom) directly connected to R 4 ;
  • R 4 is —NH 2 , —NHR 1 , —NR 1 R 2 R 6 (where R 6 ⁇ R 1 , R 2 , or —CH 2 —COOH or its salt), —NH—C(O)—, sulfobetaine, betaine, polyethylene oxide, poly(ethyleneoxide/propylene oxide/butylene oxide) grafts with any end group, H, OH, styrene sulfonate, pyridine, quaternized pyridine, alkyl-substituted pyrrolidone or pyridine, pyridine-N-oxide, imidazolinium halide, imidazolium halide, imidazol, piperidine, —OR 1 , —OH, —COOH alkali salt, sulfonate, ethoxy sulphate, pyrrolidone, caprolactam, phenyl-R 4 or naphthalene-R 5 , where
  • glyoxylated cationic polyacrylamides can be used.
  • Typical polymers of choice are those containing the cationic monomer dimethylaminoethyl methacrylate (DMAEMA) or methacrylamidopropyl trimethyl ammonium chloride (MAPTAC).
  • DMAEMA can be found in GAFQUAT and GAFFIX VC-713 polymers from ISP.
  • MAPTAC can be found in BASF's LUVIQUAT PQ11 PN and ISP's GAFQUAT HS100.
  • polymers that can be used are those that contain cationic groups in the main chain or backbone. Included in this group are:
  • polyalkylene imines such as polyethylene imine, commercially available as LUPASOL from BASF. Any molecular weight and any degree of crosslinking of this polymer can be used in the present invention.
  • adipic acid/dimethyl amino hydroxypropyl diethylene triamine copolymers such as CARTARETIN F-4 and F-23, commercially available from Sandoz;
  • polymers of the general formula: —[N(CH 3 ) 2 —(CH 2 ) x —NH—(CO)—NH—(CH 2 ) y —N(CH 3 ) 2 )—(CH 2 ) z —O—(—CH 2 ) p ] n —, with x, y, z, p 1-12, and n according to the molecular weight requirements.
  • Examples are Polyquaternium-2 (MIRAPOL A-15), Polyquater-nium-17 (MIRAPOL AD-1), and Polyquaternium-18 (MIRAPOL AZ-1).
  • polymers include cationic polysiloxanes and cationic polysiloxanes with carbon-based grafts with a net theoretical positive charge or equal to zero (mixture of cationic and anionic functional groups).
  • R 1 can also be a liquid crystalline moiety that can provide the polymer with thermotropic liquid crystalline properties.
  • R 2 can be H or CH 3 ; and R 3 can be —R 1 —R 4 , where R 4 can be —NH 2 , —NHR 1 , —NR 1 R 2 R 6 (where R 6 ⁇ R 1 , R 2 , or —CH 2 —COOH or its salt), —NH—C(O)—, —COOH, —COO— alkali salt, any C 1 -C 25 alcohol, —C(O)—NH 2 (amide), —C(O)—N(R 2 )(R 2 ′)(R 2 ′′), sulfobetaine, betaine, polyethylene oxide, poly(ethyleneoxide/propylene oxide/butylene oxide) grafts with any end group, H, —OH, styrene sulfonate, pyridine, quaternized pyridine, alkyl-substi
  • R 3 can also be —(CH 2 ) x —O—CH 2 —CH(OH)—CH 2 —N(CH 3 ) 2 —CH 2 —COOH and its salts. Any mixture of these R 3 groups can be selected.
  • X and y can be varied as long as the theoretical net charge of the polymer is zero (amphoteric) or positive.
  • polysiloxanes containing up to 5 different types of monomeric units may be used. Examples of suitable polysiloxanes are found in U.S. Pat. Nos. 4,395,541, 4,597,962 and 6,200,554.
  • Another group of polymers that can be used to improve capsule/particle deposition are phospholipids that are modified with cationic polysiloxanes. Examples of these polymers are found in U.S. Pat. No. 5,849,313, WO Patent Application 95/18096A1 and European Patent No. 0737183B1.
  • copolymers of silicones and polysaccharides and proteins can be used (e.g., those commercially available as CRODASONE brand products).
  • polymers include polyethylene oxide-co-propyleneoxide-co-butylene oxide polymers of any ethylene oxide/propylene oxide/butylene oxide ratio with cationic groups resulting in a net theoretical positive charge or equal to zero (amphoteric). Examples of such polymers are the commercially available TETRONIC brand polymers.
  • Suitable polyheterocyclic (the different molecules appearing in the backbone) polymers include the piperazine-alkylene main chain copolymers disclosed by Kashiki and Suzuki (1986) Ind. Eng. Chem. Fundam. 25:120-125.
  • Cationic PQ polymers shown in Table 1 above can also be used as a deposition aid. Additional suitable PQ polymers are listed in Table 2 below.
  • deposition aids include those described in US 2013/0330292, US 2013/0337023, US 2014/0017278.
  • microcapsule can be formulated into a capsule delivery system (e.g., a microcapsule composition) for use in consumer products.
  • a capsule delivery system e.g., a microcapsule composition
  • the capsule delivery system can be a slurry containing in an external hydrophilic solvent (e.g., water and ethanol) the capsule at a level 0.1 to 80% (preferably 1 to 65% and more preferably 5 to 45%) by weight of the capsule delivery system.
  • an external hydrophilic solvent e.g., water and ethanol
  • the capsule and its slurry prepared in accordance with the present invention is subsequently purified.
  • Purification can be achieved by washing the capsule slurry with water, e.g., deionized or double deionized water, until a neutral pH is achieved.
  • the capsule suspension can be washed using any conventional method including the use of a separatory funnel, filter paper, centrifugation and the like.
  • the capsule suspension can be washed one, two, three, four, five, six, or more times until a neutral pH, e.g., pH 6-8 and 6.5-7.5, is achieved.
  • the pH of the purified capsules can be determined using any conventional method including, but not limited to pH paper, pH indicators, or a pH meter.
  • a capsule suspension of this invention is “purified” in that it is 80%, 90%, 95%, 97%, 98% or 99% homogeneous to capsules.
  • purity is achieved by washing the capsules until a neutral pH is achieved, which is indicative of removal of unwanted impurities and/or starting materials, e.g., polyisocyanate, cross-linking agent and the like.
  • the purification of the capsules includes the additional step of adding a salt to the capsule suspension prior to the step of washing the capsule suspension with water.
  • a salt of use in this step of the invention include, but are not limited to, sodium chloride, potassium chloride or bi-sulphite salts. See US 2014/0017287.
  • the delivery system can also be spray dried to a solid form.
  • a spray dry carrier is added to a capsule delivery system to assist the removal of water from the slurry.
  • the spray dry carriers can be selected from the group consisting of carbohydrates such as chemically modified starches and/or hydrolyzed starches, gums such as gum arabic, proteins such as whey protein, cellulose derivatives, clays, synthetic water-soluble polymers and/or copolymers such as polyvinyl pyrrolidone, polyvinyl alcohol.
  • the spray dry carriers may be present in an amount from 1 to 50%, more preferably from 5 to 20%.
  • a free flow agent (anticaking agent) of silicas which may be hydrophobic (i.e. silanol surface treated with halogen silanes, alkoxysilanes, silazanes, siloxanes, etc. such as Sipernat D17, Aerosil R972 and R974 (available from Degussa), etc.) and/or hydrophilic such as Aerosil 200, Sipernat 22S, Sipernat 50S, (available from Degussa), Syloid 244 (available from Grace Davison), may be present from about 0.01% to about 10%, more preferable from 0.5% to about 5%.
  • Humectants and viscosity control/suspending agents can also be added to facilitate spray drying. These agents are disclosed in U.S. Pat. Nos. 4,428,869, 4,464,271, 4,446,032, and 6,930,078. Details of hydrophobic silicas as a functional delivery vehicle of active materials other than a free flow/anticaking agent are disclosed in U.S. Pat. Nos. 5,500,223 and 6,608,017.
  • the spray drying inlet temperature is in the range of 150 to 240° C., preferably between 170 and 230° C., more preferably between 190 and 220° C.
  • the spray-dried capsule delivery system is well suited for use in a variety of all dry (anhydrous) products: powder laundry detergent, fabric softener dryer sheets, household cleaning dry wipes, powder dish detergent, floor cleaning cloths, or any dry form of personal care products (e.g. shampoo powder, deodorant powder, foot powder, soap powder, baby powder), etc. Because of high fragrance and/or active agent concentration in the spray-dried products of the present invention, characteristics of the aforementioned consumer dry products will not be adversely affected by a small dosage of the spray-dried products.
  • the capsule delivery system can also be sprayed as a slurry onto a consumer product, e.g., a fabric care product.
  • a liquid delivery system containing capsules is sprayed onto a detergent powder during blending to make granules. See US 2011/0190191.
  • water-absorbing material such as zeolite, can be added to the delivery system.
  • granulates in a consumer product are prepared in a mechanical granulator in the presence of a granulation auxiliary such as non-acid water-soluble organic crystalline solids. See WO 2005/097962.
  • the capsule delivery system can also contain one or more other delivery system such as polymer-assisted delivery compositions (see U.S. Pat. No. 8,187,580), fiber-assisted delivery compositions (US 2010/0305021), cyclodextrin host guest complexes (U.S. Pat. No. 6,287,603 and US 2002/0019369), pro-fragrances (WO 2000/072816 and EP 0 922 084), and any combination thereof.
  • polymer-assisted delivery compositions see U.S. Pat. No. 8,187,580
  • fiber-assisted delivery compositions US 2010/0305021
  • cyclodextrin host guest complexes U.S. Pat. No. 6,287,603 and US 2002/0019369
  • pro-fragrances WO 2000/072816 and EP 0 922 084
  • the capsule delivery system can also contain one or more (e.g., two, three, four, five or six more) different capsules including different capsules of this invention and other capsules such as such as aminoplasts, hydrogel, sol-gel, coascervate capsules, polyurea/polyurethane capsules, and melamine formaldehyde capsules. More exemplary delivery systems that can be incorporated are coascervate capsules, cyclodextrin delivery systems, and pro-perfumes.
  • Polymer assisted delivery system include melt extruded flavor/fragrance utilizing high molecular weight carbohydrates, low molecular weight carbohydrates, or polymer.
  • Low molecular weight carbohydrates of a low molecular weight carbohydrate or polyol wherein said low molecular weight carbohydrate or polyol is selected from the group consisting of glucose, sucrose, maltose, lactose, corn syrup solid, erythritol, lactitol, mannitol, sorbitol, maltitol, isomalt, xylitol, trehalose, hydrogenated corn syrup, hydrogenated glucose syrup, hydrogenated maltose syrup, hydrogenated lactose syrup, starch hydrolysate, and a mixture thereof, and wherein said glassy matrix has a glass transition temperature of greater than room temperature.
  • Polymers are useful in the practice of our invention. Specific examples of polymers useful in the practice of our invention are as follows: DYLAN® of low density polyethylene (DYLAN® is a trademark owned by the Atlantic Richfield Company of Los Angeles, Calif.), DYLITE® of expandable polystyrene compositions (DYLITE® is a trademark of the Atlantic Richfield Company of Los Angeles, Calif.), SUPER DYLAN® of high density polyethylene (SUPER DYLAN® a trademark of the Atlantic Richfield Company of Los Angeles, Calif.). Blended polyethylene and carbon black as specifically taught in U.S. Pat. No. 4,369,267. Polystyrene as disclosed in U.S. Pat. No. 4,369,227.
  • Polyene/alpha-olefin copolymers as exemplified and disclosed in U.S. Pat. No. 4,369,291.
  • Poly-alpha-olefins as exemplified in Canadian Letters Pat. Nos. 1,137,069 and 1,137,067.
  • Polymeric compositions as disclosed in Canadian Letters Pat. No. 1,137,068.
  • Polyethylene oxides as disclosed in Canadian Letters Pat. No. 1,137,065.
  • Olefin polymers and co-polymers as disclosed in Canadian Letters Pat. No. 1,139,737.
  • Chlorinated PVC as disclosed in Polymer 1982, 23 (7, Suppl.), 1051-6.
  • Polyepsilon caprolactone co-polymers made by means of alcohol initiated polymerization as disclosed in J. Polym. Sci. Polym. Chem. Ed. 1982, 20(2), pages 319-26.
  • Styrene acrylonitrile co-polymers as disclosed in Diss. Abstracts, Int. B, 1982, 42(8), 3346 and abstracted at Chem. Abstracts 96:143750n (1982).
  • Co-polymers of epsilon caprolactone with 1,4-butane diol as disclosed at Kauch. Rezine, 1982, (2), 8-9, abstracted at Chem.
  • Polyesters as disclosed in U.S. Pat. No. 4,326,010. Chlorinated polyethylene as disclosed by Belorgey, et. al. J. Polym. Sci. Polym. Phys. Ed. 1982, 20(2), 191-203. Plasticized polyepsilon caprolactone co-polymers containing dimethyl phthalate plasticizers as set forth in Japanese Pat. No. J81/147844. Maleic anhydride modified adducts of polyepsilon caprolactone polyols and ethylenically unsaturated monomer as disclosed in U.S. Pat. No. 4,137,279.
  • Suitable plasticizers include water; glycerol; propylene glycol; aqueous solutions of glycerol, propylene glycol, monosaccharides, and disaccharides; and invert and high fructose corn syrups.
  • Emulsifier surface-active agent, i.e. an emulsifier can be added to the dry blend, or preferably added to the liquid flavor mix which is ultimately injected into the metering zone of the extruder.
  • emulsifiers can be from the class of distilled monoglycerides, mono- and diglyceride blends, propyleneglycol monoglycerides, lecithin, modified lecithins, acetylated monoglycerides, lactylated monoglycerides, lactylated propyleneglycol monoglycerides, sorbitan esters, sorbitan-polyoxyethylene [20] monoglycerides, polyglycerol esters, DATEM's (diacetyltartarate esters of monoglycerides), succinylated esters of monoglycerides and polyoxyethylenepropylene copolymers and mixtures thereof.
  • Most preferred surfactants are the sorbitan-polyoxyethylene
  • the matrix is comprised of one or more of the following materials: sugars such as glucose, fructose, lactose, galactose, ribose, xylose, sucrose, maltose; polyols such as glycerin and propylene glycol; corn syrups, maltodextrin, fats, silicone dioxide, polyhydric alcohols, corn syrup solids, starches, modified starches, emulsifiers and food acids.
  • the level of maltodextrin used in the matrix comprises from about 25 to about 98 weight percent, preferably form about 35 to about 75 weight percent, the maltodextrin
  • flavors and fragrance may also be combined with a variety of solvents which serve to increase the compatibility of the various materials, increase the overall hydrophobicity of the blend, influence the vapor pressure of the materials, or serve to structure the blend.
  • Solvents performing these functions are well known in the art and include mineral oils, triglyceride oils, silicone oils, fats, waxes, fatty alcohols, diisodecyl adipate, and diethyl phthalate among others.
  • emulsifiers including monoglycerides of fatty acids, distilled succinylated monoglycerides of fatty acids, sorbitan fatty acid esters; distilled acetylated monoglycerides of fatty acids, monoglycerides of fatty acids.
  • Proteins useful in coacervation processes include albumins, vegetable globulins and gelatines.
  • the gelatine may be fish, pork, beef, and/or poultry gelatine, for example.
  • the protein is fish, beef or poultry gelatine.
  • the protein is warm water fish gelatine.
  • non-protein polymers useful in complex coacervation methods include, in particular, negatively charged polymers.
  • they may be selected from gum arabic, xanthan, agar, alginate salts, cellulose derivatives, for example carboxymethyl cellulose, pectinate salts, carrageenan, polyacrylic and methacrylic acid, and/or mixtures thereof.
  • Further suitable non-proteins can be derived from the literature, for example from to WO 2004/022221, page 4, lines 27-29
  • a cross-linking agent is typically used to harden the coating layer.
  • Suitable cross-linking agents include formaldehyde, acetaldehyde, glutaraldehyde, glyoxal, chrome alum, or transglutaminase.
  • transglutaminase is used at 10-100, preferably 30-60 activity units per gram of gelatine. This enzyme is well described and commercially obtainable.
  • This technology approach uses a cyclic oligosaccharide or cyclodextrin to improve the delivery of perfume.
  • a perfume and cyclodextrin (CD) complex is formed.
  • Such complexes may be preformed, formed in-situ, or formed on or in the situs. See, e.g., WO 2013/109798 A2 and US 2011/0308556 A1.
  • nonlimiting examples include aromatic or non-aromatic imines (Schiff bases), oxazolidines, beta-keto esters, orthoesters, compounds comprising one or more beta-oxy or beta-thio carbonyl moieties capable of releasing a perfume (e.g., an alpha, beta-unsaturated ketone, aldehyde or carboxylic ester).
  • a perfume e.g., an alpha, beta-unsaturated ketone, aldehyde or carboxylic ester.
  • the typical trigger for perfume release is exposure to water; although other triggers may include enzymes, heat, light, pH change, autoxidation, a shift of equilibrium, change in concentration or ionic strength and others. Suitable pro-perfumes and methods of making same can be found in U.S. Pat. Nos.
  • Any compound, polymer, or agent discussed above can be the compound, polymer, or agent itself as shown above, or its salt, precursor, hydrate, or solvate.
  • a salt can be formed between an anion and a positively charged group on the compound, polymer, or agent. Suitable anions include chloride, bromide, iodide, sulfate, nitrate, phosphate, citrate, methanesulfonate, trifluoroacetate, acetate, malate, tosylate, tartrate, fumurate, glutamate, glucuronate, lactate, glutarate, and maleate.
  • a salt can also be formed between a cation and a negatively charged group on the compound, polymer, or agent.
  • Suitable cations include sodium ion, potassium ion, magnesium ion, calcium ion, and an ammonium cation (e.g., tetramethylammonium ion).
  • a precursor can be ester and another suitable derivative, which, during the process of preparing a polyurea or polyurethane capsule composition of this invention, is capable of converting to the compound, polymer, or agent and being used in preparing the polyurea or polyurethane capsule composition.
  • a hydrate refers to the compound, polymer, or agent that contains water.
  • a solvate refers to a complex formed between the compound, polymer, or agent and a suitable solvent.
  • a suitable solvent can be water, ethanol, isopropanol, ethyl acetate, acetic acid, and ethanolamine.
  • Certain compounds, polymers, and agents have one or more stereocenters, each of which can be in the R configuration, the S configuration, or a mixture. Further, some compounds, polymers, and agents possess one or more double bonds wherein each double bond exists in the E (trans) or Z (cis) configuration, or combinations thereof.
  • the compounds, polymers, and agents include all possible configurational stereoisomeric, regioisomeric, diastereomeric, enantiomeric, and epimeric forms as well as any mixtures thereof.
  • lysine used herein includes L-lysine, D-lysine, L-lysine monohydrochloride, D-lysine monohydrochloride, lysine carbonate, and so on.
  • arginine includes L-arginine, D-arginine, L-arginine monohydrochloride, D-arginine monohydrochloride, arginine carbonate, arginine monohydrate, and etc.
  • Guanidine includes guanidine hydrochloride, guanidine carbonate, guanidine thiocyanate, and other guanidine salts including their hydrates.
  • Ornithine include L-ornithine and its salts/hydrates (e.g., monohydrochloride) and D-ornithine and its salts/hydrates (e.g., monohydrochloride).
  • the delivery systems of the present invention are well-suited for use, without limitation, in the following products:
  • polyfunctional isocyanate “multifunctional isocyanate,” and “polyisocyanate” are used interchangeably and refer to a compound having two or more isocyanate (—NCO) groups.
  • polyfunctional amine “multifunctional amine,” and “polyamine” are used interchangeably and refer to a compound containing two or more primary or secondary amine groups. These terms also refer to a compound containing one or more primary/secondary amine groups and one or more hydroxyl groups.
  • polyfunctional alcohol “multifunctional alcohol,” “poly alcohol,” and “polyol” are used interchangeably and refer to a compound having two or more hydroxyl groups.
  • a microcapsule composition of this invention i.e., Composition 1
  • Composition 1 was prepared following the procedure described below.
  • a polyurea microcapsule i.e., Microcapsule 1
  • a research fragrance accord International Flavors and Fragrance, Union Beach, N.J.
  • Neobee oil Commercially available from Stepan, Chicago, Ill., USA
  • Lupranate®M20 BASF corporation, Wyandotte, Mich., USA
  • an aqueous solution (267.13 g) containing 0.98% Morwet D-425 (Akzo Nobel, Fort Worth, Tex., USA) and 0.98% polyvinylpyrrolidone (Luviskol®K90, BASF, Ludwigshafen, Germany) was used as an aqueous phase.
  • the oil phase was then emulsified into the aqueous phase to form a fragrance emulsion under shearing (Ultra Turrax®, T25 Basic, IKA® WERKE) at 6500 rpm for three minutes.
  • HMDA Hexamethylene diamine
  • INVISTA 18.9 g, 40% aqueous solution, INVISTA, Wichita, Kans., USA
  • the mixer speed was maintained the same throughout the process.
  • the capsule slurry was cured at 55° C. for two hours. Cooling the slurry to room temperature yielded Microcapsule 1 as a slurry.
  • Microcapsule 1 thus prepared 525 g was mixed with 12 g of Aculyn 33 (containing about 28 wt % of a copolymer of acrylic acid and acrylate, commercially available from Dow Chemical, the Netherlands) for 30 minutes. After the pH was adjusted to 8 using 50% citric acid (approximately 6 g used), 36 g of Polyquaternium-6 (PQ-6, Merquat®100 42 wt % aqueous solution, commercially available from Lubrizol, USA) and 21 g of water were added under constant mixing to give Composition 1, which contained 2 wt % Aculyn 33 (i.e., 0.56 wt % of the copolymer of acrylic acid and acrylate) as a viscosity control agent and 2.5 wt % polyquaternium-6 as a deposition aid agent.
  • Aculyn 33 containing about 28 wt % of a copolymer of acrylic acid and acrylate, commercially available from Dow Chemical, the Netherlands
  • Composition 2 was prepared following the same procedure as Composition 1 except that 18 g of Aculyn 33 was added to 525 g of Microcapsule 1. Composition 2 thus prepared contained 3 wt % Aculyn 33 (i.e., 0.84 wt % of the copolymer) and 2.5 wt % PQ-6.
  • Composition 3 was prepared following the same procedure as Composition 1 except that 24 g of Aculyn 33 was added to 525 g of Microcapsule 1.
  • Composition 3 contained 4 wt % Aculyn 33 (i.e., 1.12 wt % of the copolymer) and 2.5 wt % PQ-6.
  • Composition 4 was prepared following the same procedure as Composition 1 using, instead of Aculyn 33, 4.2 g of 3% Keltrol T Plus aqueous solution (xanthan gum, a high molecular weight polysaccharide, commercially available from CP Kelco, Belgium) in 525 g of Microcapsule 1.
  • Composition 4 contained 0.021% Keltrol T Plus as the viscosity control agent and 2.5 wt % PQ-6.
  • Composition 5 was prepared following the same procedure as Composition 1 except that 6 g of 3% Keltrol T Plus solution, instead of Aculyn 33, was added to 525 g of Microcapsule 1. Composition 5 contained 0.03% Keltrol T Plus and 2.5 wt % PQ-6.
  • Composition 6 was prepared following the same procedure as Composition 1 except that 9 g of 3% Keltrol T Plus solution, instead of Aculyn 33, was added to 525 g of Microcapsule 1.
  • Composition 5 contained 0.045% Keltrol T Plus and 2.5 wt % PQ-6.
  • Composition 7 was prepared by mixing 525 g of Microcapsule 1 with 18 g of Aculyn 33. Note that no PQ-6 was added. Composition 7 contained 3% Aculyn 33 (i.e., 0.84 wt % of the copolymer).
  • Composition 8 was prepared by mixing 24 g of Aculyn 33 with 525 g of Microcapsule 1. Composition 8 contained 4% Aculyn 33 (i.e., 1.12 wt % of the copolymer).
  • Comparative Composition 1′ A comparative composition, i.e., Comparative Composition 1′, was prepared by mixing 525 g of Microcapsule 1, 36 g of PQ-6 and 39 g of water. Comparative Composition 1′ did not contain any viscosity control agent.
  • compositions 7-10 and Microcapsule 1 were measured using a viscometer Anton Paar MCR 302 Rheometer. Before measurement, each sample was stirred with a spatula to ensure homogeneity. After the viscometer performed a pre-shearing for 5 minutes, the viscosity was analyzed at a shear rate of 21 s ⁇ 1 . For each sample, 15 viscosity readings were obtained. The average viscosity readings were reported in Tables 5 and 6 below.
  • Compositions 1-10, Microcapsule 1, and Comparative Composition 1′ were evaluated for water separation as an indication of storage stability. After being stored in predetermined conditions, in some samples, water was separated as a layer, which was measured using a graduated cylinder. The water separation was calculated as volume percent (v %) of the water layer as compared to the total volume of the composition including the water layer. The water separation v % results were summarized in Tables 3-7 below.
  • Microcapsule 1, Comparative Composition 1′, and Compositions 1-3 were stored at 4° C. for 4 weeks to evaluate their water separation. The results were summarized in Table 3 below.
  • Microcapsule 1, Comparative Composition 1′, and Compositions 5 and 6 were stored at 4° C. for 4 weeks for water separation. The results were summarized in Table 4 below.
  • Microcapsule 1, and Compositions 7 and 8 were stored at 37° C. for 8 weeks. At the end of the storage, the samples were evaluated for their viscosity and water separation. The results were summarized in Table 5 below.
  • Viscosity and water separation at 37° C. after 8 weeks Viscosity Control Viscosity Water Sample agent (%) (cP, at 21 Hz) separation, % Microcapsule 1 (none) 263 8 Composition 7 Aculyn 33, 3% 557 2 Composition 8 Aculyn 33, 4% 983 2
  • Aculyn 33 can also stabilize microcapsule compositions containing two or more different capsules.
  • Two compositions, i.e., Compositions 9 and 10 were prepared by mixing a melamine-formaldehyde microcapsule, a polyurea microcapsule, and Aculyn 33 at the level showing in Table 6 below.
  • the polyurea microcapsule i.e., Microcapsule 1
  • Microcapsule 1 was prepared according to the procedure described in Example 1.
  • a melamine-formaldehyde microcapsule i.e., Microcapsule 2 was prepared following the procedure described in US20070138673.
  • a research fragrance oil was admixed with 20 parts by weight of NEOBEE-M5 solvent thereby forming a microcapsule core oil.
  • the uncoated capsules were prepared by creating a polymeric wall to encapsulate microcapsule core oil droplets.
  • a copolymer of acrylamide and acrylic acid was first dispersed in water together with a methylated melamine-formaldehyde resin. These two components were allowed to react under acidic conditions.
  • the microcapsule core oil was then added into the solution and droplets of the desired size were achieved by high shear homogenization.
  • the resultant microcapsule slurry was cured at 80° C. for 1 hour.
  • the resulting microcapsule slurry contained about 55% water and about 45% filled microcapsules (10% microcapsule wall together with 35% the microcapsule core consisting of 80% fragrance oil and 20% NEOBEE M-5).
  • the thus prepared Microcapsule 3 had a pH of about 5.
  • compositions 9 and 10 were evaluated for the viscosity and water separation after stored at 37° C. for 8 weeks. The results were shown in Table 6 below.
  • Aculyn 33 was used to stabilize microcapsule compositions containing melamine-formaldehyde microcapsules.
  • Viscosity and water separation at 37° C. for 8 weeks Viscosity (cP, at Water Sample Components, % 21 Hz) separation, % Composition 9 Microcapsule 1, 50% 860 0 Microcapsule 2, 50% Aculyn 33, 3% Composition 10 Microcapsule 1, 25% 930 0 Microcapsule 2, 75% Aculyn 33, 3%
  • compositions 11-14 were prepared using Microcapsule 2 and Aculyn 33.
  • Composition 11 contained 1% Aculyn 33 (i.e., 0.28 wt % of the copolymer of acylic acid and acrylate) by weight of the composition.
  • Composition 12 contained 2% Aculyn 33 (i.e., 0.56 wt % of the copolymer).
  • Composition 13 contained 3% Aculyn 33 (i.e., 0.84 wt % of the copolymer).
  • Composition 14 contained 4% Aculyn 33 (i.e., 1.12 wt % of the copolymer).
  • Microcapsule 3 and Compositions 11-14 were stored at 20 or 45° C. for 4 weeks. Their water separation % was measured. The results are shown in Table 7 below.
  • Microcapsule 2 and Composition 12 were also stored at 20 or 45° C. for a prolonged time. After 24 weeks at 20° C., Microcapsule 2 had a water separation of 15% by volume of the composition. By contrast, Composition 12 showed only 6% water separation. After 24 weeks at 45° C., Microcapsule 2 had a water separation of 28% and Composition 12 had a water separation of only 8%.
  • Aculyn 33 unexpectedly stabilized microcapsules at an elevated temperature (e.g., 45° C.) for a prolonged period of storage.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
US16/334,038 2016-09-16 2017-09-15 Microcapsule compositions stabilized with viscosity control agent Abandoned US20190270064A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/334,038 US20190270064A1 (en) 2016-09-16 2017-09-15 Microcapsule compositions stabilized with viscosity control agent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662395586P 2016-09-16 2016-09-16
US16/334,038 US20190270064A1 (en) 2016-09-16 2017-09-15 Microcapsule compositions stabilized with viscosity control agent
PCT/US2017/051916 WO2018053356A1 (fr) 2016-09-16 2017-09-15 Compositions de microcapsules stabilisées avec des agents de régulation de viscosité

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2017/051916 A-371-Of-International WO2018053356A1 (fr) 2015-12-30 2017-09-15 Compositions de microcapsules stabilisées avec des agents de régulation de viscosité

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/314,314 Continuation US20210268467A1 (en) 2016-09-16 2021-05-07 Microcapsule compositions stabilized with viscosity control agents

Publications (1)

Publication Number Publication Date
US20190270064A1 true US20190270064A1 (en) 2019-09-05

Family

ID=61618980

Family Applications (2)

Application Number Title Priority Date Filing Date
US16/334,038 Abandoned US20190270064A1 (en) 2016-09-16 2017-09-15 Microcapsule compositions stabilized with viscosity control agent
US17/314,314 Pending US20210268467A1 (en) 2016-09-16 2021-05-07 Microcapsule compositions stabilized with viscosity control agents

Family Applications After (1)

Application Number Title Priority Date Filing Date
US17/314,314 Pending US20210268467A1 (en) 2016-09-16 2021-05-07 Microcapsule compositions stabilized with viscosity control agents

Country Status (6)

Country Link
US (2) US20190270064A1 (fr)
EP (2) EP3512625B1 (fr)
CN (2) CN109689197B (fr)
ES (1) ES2950434T3 (fr)
MX (1) MX2019003078A (fr)
WO (1) WO2018053356A1 (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112293414A (zh) * 2020-09-28 2021-02-02 广州立白企业集团有限公司 杀菌除异味的组合物及其制备方法
US20210292252A1 (en) * 2020-03-20 2021-09-23 Oms Investments, Inc. Fertilizer compositions having slow-release nitrogen compounds and methods of forming thereof
US20210371349A1 (en) * 2018-04-25 2021-12-02 Oms Investments, Inc. Fertilizer compositions having slow-release nitrogen compounds and methods of forming thereof
US11326133B2 (en) * 2018-04-10 2022-05-10 Rohm And Haas Company Anti-redeposition additive for laundry detergent
US20220152573A1 (en) * 2020-11-19 2022-05-19 The Procter & Gamble Company Consumer product comprising biodegradable delivery particles
US20220195350A1 (en) * 2020-12-23 2022-06-23 The Procter & Gamble Company Anti-microbial liquid detergent composition
CN115003409A (zh) * 2020-01-29 2022-09-02 奇华顿股份有限公司 方法
US20220408745A1 (en) * 2019-09-13 2022-12-29 Meiji Co., Ltd. Solid food and solid milk having hole penetrating first face and second face
CN115725252A (zh) * 2022-11-25 2023-03-03 浙江福斯特新材料研究院有限公司 树脂组合物、母粒、液体胶黏剂、胶膜及应用
WO2023030855A1 (fr) * 2021-08-31 2023-03-09 Givaudan Sa Neutralisation de mauvaises odeurs
US11747701B2 (en) 2019-12-23 2023-09-05 E Ink Corporation Color electrophoretic layer including microcapsules with nonionic polymeric walls
US12091643B2 (en) 2020-12-23 2024-09-17 The Procter & Gamble Company Process of removing microorganism from an article of clothing

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020146691A1 (fr) 2019-01-11 2020-07-16 Encapsys, Llc Incorporation de chitosane dans une paroi de microcapsule
EP3952823A4 (fr) * 2019-04-12 2023-08-30 International Flavors & Fragrances Inc. Produit de consommation avec des compositions de microcapsules à coeur-enveloppe biodégradables à libération contrôlée
CN110218776A (zh) * 2019-06-14 2019-09-10 苏州叠代生物科技有限公司 Pcr油相组合物及其制备方法
CN110237786B (zh) * 2019-06-19 2021-05-18 中南林业科技大学 一种释放可控的抑菌精油微胶囊的制备方法
CN110358250A (zh) * 2019-08-12 2019-10-22 成都玉龙化工有限公司 一种高保水性三聚氰胺泡沫及其制备方法
EP4025172A4 (fr) * 2019-09-05 2023-09-06 Pure Green Pharmaceuticals, Inc. Additif contenant un cannabinoïde et son procédé
WO2021073774A1 (fr) * 2019-10-16 2021-04-22 Symrise Ag Microcapsules de polyurée et systèmes tensioactifs liquides les contenant
CN110699194B (zh) * 2019-10-18 2021-06-04 广州大白生物科技有限公司 一种稳定分散微胶囊香精的洗衣液
CN110946134B (zh) * 2019-10-31 2022-09-13 华南农业大学 一种以聚氨酯为载体的农药制剂及其制备方法
JPWO2021132727A1 (fr) 2019-12-27 2021-07-01
CA3157322A1 (fr) * 2020-02-14 2021-08-19 Encapsys, Llc Capsules de polyuree reticulees avec du chitosane
CN112391834B (zh) * 2020-09-28 2022-11-01 广州立白企业集团有限公司 除菌祛异味持久留香的组合物及其制备方法
CN112656727A (zh) * 2020-12-30 2021-04-16 刁永飞 一种固发养发定型剂及其制备方法
CN112980607A (zh) * 2021-02-26 2021-06-18 中山百科清洁用品制造有限公司 一种长效驱蚊洗衣液及其制备方法
WO2022268645A1 (fr) * 2021-06-21 2022-12-29 Agfa Nv Résine contenant une encre aqueuse pour jet d'encre et procédé d'enregistrement
JP2023008935A (ja) 2021-06-30 2023-01-19 花王株式会社 マイクロカプセル水分散液
CN114031739B (zh) * 2021-11-24 2023-03-28 杨骏 醛化合物发泡的环保聚氨酯泡沫塑料及其制造方法和应用
WO2023232515A1 (fr) * 2022-05-31 2023-12-07 Unilever Ip Holdings B.V. Particules de lessive
CN116713020B (zh) * 2023-06-02 2024-05-24 苏州科技大学 一种水包油型皮克林乳液及其制备方法与应用

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930078B2 (en) * 2002-04-22 2005-08-16 The Procter & Gamble Company Shampoo containing a cationic guar derivative
US20070042182A1 (en) * 2003-05-11 2007-02-22 Arie Markus Encapsulated essential oils
US20130337023A1 (en) * 2009-09-18 2013-12-19 International Flavors & Fragrances Inc. Polyurea capsules prepared with aliphatic isocyanates and amines
US20160184196A1 (en) * 2014-12-16 2016-06-30 The Procter & Gamble Company Compositions Providing Delayed Release of Actives
WO2016144798A1 (fr) * 2015-03-06 2016-09-15 International Flavors & Fragrances Inc. Compositions à microcapsule haute performance
US9738817B2 (en) * 2012-10-09 2017-08-22 Avery Dennison Corporation Adhesives and related methods

Family Cites Families (227)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800457A (en) 1953-06-30 1957-07-23 Ncr Co Oil-containing microscopic capsules and method of making them
NL104256C (fr) 1958-12-22
US3074845A (en) 1959-10-14 1963-01-22 Plant Products Corp Particulate pesticidal composition coated with an amido-aldehyde resin polymerized in situ
US3415758A (en) 1960-03-09 1968-12-10 Ncr Co Process of forming minute capsules en masse
US3516941A (en) 1966-07-25 1970-06-23 Minnesota Mining & Mfg Microcapsules and process of making
GB1316464A (en) 1969-08-22 1973-05-09 Kanebo Ltd Process of treating fibrous articles with microcapsules containing hydrophobic treating agent
US3516846A (en) 1969-11-18 1970-06-23 Minnesota Mining & Mfg Microcapsule-containing paper
US4285720A (en) 1972-03-15 1981-08-25 Stauffer Chemical Company Encapsulation process and capsules produced thereby
ZA734721B (en) 1972-07-14 1974-03-27 Procter & Gamble Detergent compositions
US3975350A (en) 1972-08-02 1976-08-17 Princeton Polymer Laboratories, Incorporated Hydrophilic or hydrogel carrier systems such as coatings, body implants and other articles
US3862058A (en) 1972-11-10 1975-01-21 Procter & Gamble Detergent compositions containing a smectite-type clay softening agent
US3954632A (en) 1973-02-16 1976-05-04 The Procter & Gamble Company Softening additive and detergent composition
JPS5614784B2 (fr) 1973-07-14 1981-04-06
GB1462484A (en) 1974-01-31 1977-01-26 Procter & Gamble Ltd Detergent compositions
US4001140A (en) 1974-07-10 1977-01-04 Ncr Corporation Capsule manufacture
US4031265A (en) 1975-06-18 1977-06-21 The United States Of America As Represented By The Secretary Of Agriculture Method of reducing bitterness in citrus juices
US4145184A (en) 1975-11-28 1979-03-20 The Procter & Gamble Company Detergent composition containing encapsulated perfume
GB1524307A (en) 1976-06-16 1978-09-13 Monsanto Europe Sa Encapsulation process
US4156066A (en) 1977-06-23 1979-05-22 Tyndale Plains - Hunter Ltd. Polyurethane polymers characterized by lactone groups and hydroxyl groups in the polymer backbone
JPS602100B2 (ja) 1977-09-28 1985-01-19 三菱製紙株式会社 微小カプセルの製造方法
US4137279A (en) 1977-12-27 1979-01-30 Union Carbide Corporation Copolymers of polycaprolactone derivatives and ethylenically unsaturated monomers
IT1092448B (it) 1978-02-09 1985-07-12 Montedison Spa Catalizzatori per la polimerizzazione delle alfa-olefine
IT1113129B (it) 1978-04-12 1986-01-20 Montedison Spa Catalizzatori e componenti di catalizzatori per la polimerizzazione delle olefine
JPS584925B2 (ja) 1978-06-21 1983-01-28 日石三菱株式会社 ポリオレフインの製造方法
IT1098272B (it) 1978-08-22 1985-09-07 Montedison Spa Componenti,di catalizzatori e catalizzatori per la polimerizzazione delle alfa-olefine
DE2842389C2 (de) 1978-09-29 1984-04-12 Robert Bosch Gmbh, 7000 Stuttgart Vorrichtung zur Einstellung des Drehmomentes einer Brennkraftmaschine
JPS5923561B2 (ja) 1979-02-06 1984-06-02 三井化学株式会社 オレフインの重合方法
US4280833A (en) 1979-03-26 1981-07-28 Monsanto Company Encapsulation by interfacial polycondensation, and aqueous herbicidal composition containing microcapsules produced thereby
US4347157A (en) 1979-04-25 1982-08-31 Sumitomo Chemical Company, Limited Catalysts for the polymerization of olefins
DE2917403A1 (de) 1979-04-28 1980-11-06 Bayer Ag Polybutadien/ alpha -olefin-copolymere
CA1113220A (fr) 1979-06-01 1981-12-01 Chue-Kwok J. Keung Methode de dispersion du noir de fumee dans le polyethylene
US4326010A (en) 1979-06-15 1982-04-20 E. I. Du Pont De Nemours And Company Additive in a photopolymerizable composition for reducing its adhesion to a support film
DE2925625C2 (de) 1979-06-26 1981-10-01 Chemische Werke Hüls AG, 4370 Marl Verfahren zur Steigerung der Aktivität und zur Verlängerung der Standzeit bei hoher Selektivität von Silber-Träger-Katalysatoren für den Einsatz zur Ethylenoxid-Synthese
JPS5651238A (en) 1979-10-02 1981-05-08 Fuji Photo Film Co Ltd Production of microminiature capsule
FR2471996A1 (fr) 1979-12-21 1981-06-26 Oreal Nouveaux polymeres du type ionenes, leur preparation et leur application
US4387090A (en) 1980-12-22 1983-06-07 The Procter & Gamble Company Hair conditioning compositions
US4396670A (en) 1980-04-08 1983-08-02 The Wiggins Teape Group Limited Process for the production of microcapsules
DE3030053A1 (de) 1980-08-08 1982-03-25 Basf Ag, 6700 Ludwigshafen Teilchenfoermige, treibmittelhaltige styrolpolymerisate und deren verwendung
US4446032A (en) 1981-08-20 1984-05-01 International Flavors & Fragrances Inc. Liquid or solid fabric softener composition comprising microencapsulated fragrance suspension and process for preparing same
US4464271A (en) 1981-08-20 1984-08-07 International Flavors & Fragrances Inc. Liquid or solid fabric softener composition comprising microencapsulated fragrance suspension and process for preparing same
US4428869A (en) 1981-08-20 1984-01-31 International Flavors & Fragrances Inc. Cologne consisting of microcapsule suspension
US4525520A (en) 1983-03-28 1985-06-25 Kanzaki Paper Manufacturing Company, Ltd. Method of preparing microcapsules
US4424134A (en) 1983-06-15 1984-01-03 The Procter & Gamble Company Aqueous fabric softening compositions
LU84894A1 (fr) 1983-07-01 1985-04-17 Oreal Composition capillaire et procede de traitement des cheveux
US4518615A (en) 1983-08-23 1985-05-21 Warner-Lambert Company Non-adhesive chewing gum base composition
US4515705A (en) 1983-11-14 1985-05-07 The Procter & Gamble Company Compositions containing odor purified proteolytic enzymes and perfumes
US4563212A (en) 1983-12-27 1986-01-07 Monsanto Company High concentration encapsulation by interfacial polycondensation
DE3479187D1 (en) 1984-03-21 1989-09-07 Richardson Vicks Ltd Hair treating composition
EP0158449B1 (fr) 1984-03-30 1987-11-04 Stauffer Chemical Company Micro-capsules et procédé de micro-encapsulage
IL74842A (en) 1984-04-12 1988-04-29 Tate & Lyle Plc Method of modifying taste
LU85303A1 (fr) 1984-04-13 1985-11-27 Oreal Composition capillaire et procede de traitement des cheveux
US5089339A (en) 1984-12-24 1992-02-18 Pietsch Guenter Aminoplast microencapsulation system
US4681806A (en) 1986-02-13 1987-07-21 Minnesota Mining And Manufacturing Company Particles containing releasable fill material and method of making same
US4721620A (en) 1986-04-01 1988-01-26 Warner-Lambert Company Polyvinylacetate bubble gum base composition
GB2188653A (en) 1986-04-02 1987-10-07 Procter & Gamble Biodegradable fabric softeners
US4714562A (en) 1987-03-06 1987-12-22 The Procter & Gamble Company Automatic dishwasher detergent composition
EP0299575B1 (fr) 1987-07-14 1994-01-12 The Procter & Gamble Company Compositions détergentes
EP0313146B2 (fr) 1987-10-19 2001-09-05 The Procter & Gamble Company Compositions détergentes
US4830855A (en) 1987-11-13 1989-05-16 Landec Labs, Inc. Temperature-controlled active agent dispenser
EP0321750B2 (fr) 1987-12-21 1993-03-24 Papierfabrik August Koehler AG Procédé de fabrication de microcapsules, les microcapsules ainsi préparées et leur utilisation
US4785048A (en) * 1988-02-08 1988-11-15 Moore Business Forms, Inc. Polyurea and polyurea-epoxy microcapsules
US5013473A (en) 1988-02-25 1991-05-07 Minnesota Mining And Manufacturing Company Encapsulated cosmetic materials and process of making
GB8808239D0 (en) 1988-04-08 1988-05-11 Knowsley Contract Chem Ltd Catalyst & its use in alkylation & acylation
US4968451A (en) 1988-08-26 1990-11-06 The Procter & Gamble Company Soil release agents having allyl-derived sulfonated end caps
US5049182A (en) 1989-02-03 1991-09-17 Ici Americas Inc. Single-package agricultural formulations combining immediate and time-delayed delivery
CA2009047C (fr) 1989-02-27 1999-06-08 Daniel Wayne Michael Microcapsules renfermant un noyau liquide hydrophobe
US5169552A (en) 1989-10-04 1992-12-08 The Procter & Gamble Company Stable thickened liquid cleaning composition containing bleach
US5085857A (en) 1989-12-04 1992-02-04 Chesebrough-Pond's Usa Co. Conditioning shampoo comprising a surfactant, a non-volatile silicone oil and guar hydroxypropyltrimonium chloride as a cationic conditioning polymer
JP2539690B2 (ja) 1990-02-19 1996-10-02 株式会社ホーネンコーポレーション 均一な粒子径を有するメラミン樹脂架橋粒子の製造法
FR2662175B1 (fr) 1990-05-18 1994-05-13 Oreal Compositions de lavage a base de silicone et d'alcools gras a groupements ether et/ou thioether ou sulfoxyde.
US5637618A (en) 1990-06-01 1997-06-10 Bioresearch, Inc. Specific eatable taste modifiers
GB9021061D0 (en) 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
US5194639A (en) 1990-09-28 1993-03-16 The Procter & Gamble Company Preparation of polyhydroxy fatty acid amides in the presence of solvents
US5665822A (en) 1991-10-07 1997-09-09 Landec Corporation Thermoplastic Elastomers
US5204185A (en) 1990-12-11 1993-04-20 The Standard Register Company Microencapsulation process using melamine-formaldehyde and microcapsules produced thereby
US5268130A (en) 1990-12-20 1993-12-07 The Standard Register Company Melamine formaldehyde microencapsulation in aqueous solutions containing high concentrations of organic solvent
HU215771B (hu) 1991-02-06 2000-09-28 Zeneca Ag Products Inc. 2-Klór-N-(etoxi-metil)-6'-etil-o-aceto-toluidid herbicidet tartalmazó kapszulák és eljárás előállításukra
FR2673179B1 (fr) 1991-02-21 1993-06-11 Oreal Ceramides, leur procede de preparation et leurs applications en cosmetique et en dermopharmacie.
US5093136A (en) 1991-05-08 1992-03-03 Nabisco Brands, Inc. Dual gum base bubble gum
US5266336A (en) 1991-11-12 1993-11-30 Wm. Wrigley Jr. Company High flavor impact non-tack chewing gum with reduced plasticization
ATE181956T1 (de) 1992-05-12 1999-07-15 Procter & Gamble Konzentrierte flüssige gewebeweichmacherzusammensetzungen mit biologisch abbaubaren gewebeweichmachern
DK0646164T3 (da) 1992-06-15 1997-11-03 Procter & Gamble Væskeformige vaskedetergentsammensætninger med siliconeantiskummiddel
US5288417A (en) 1992-07-06 1994-02-22 Lever Brothers Company, Division Of Conopco, Inc. Fabric conditioning compositions and process for making them
US5458810A (en) 1992-07-15 1995-10-17 The Procter & Gamble Co. Enzymatic detergent compositions inhibiting dye transfer
EP0581753B1 (fr) 1992-07-15 1998-12-09 The Procter & Gamble Company Compositions pour éviter le transfert de colorant contenant des agents dispersants polymères
US5458809A (en) 1992-07-15 1995-10-17 The Procter & Gamble Co. Surfactant-containing dye transfer inhibiting compositions
EP0581752B1 (fr) 1992-07-15 1998-12-09 The Procter & Gamble Company Compositions pour éviter le transfert de colorant contenant des adjuvants
JP2615345B2 (ja) 1992-12-28 1997-05-28 三栄源エフ・エフ・アイ株式会社 呈味改善剤及び呈味改善方法
WO1994020597A1 (fr) 1993-03-01 1994-09-15 The Procter & Gamble Company Compositions adoucissantes pour tissus concentrees et biodegradables a base d'ammonium quaternaire et composes contenant des chaines d'acide gras insature a indice d'iode intermediaire
US5403499A (en) 1993-04-19 1995-04-04 Lever Brothers Company, Division Of Conopco, Inc. Concentrated fabric conditioning compositions
EP0723579B1 (fr) 1993-10-14 2007-05-02 The Procter & Gamble Company Compositions de nettoyage contenant une protease
US5466802A (en) 1993-11-10 1995-11-14 The Procter & Gamble Company Detergent compositions which provide dye transfer inhibition benefits
US6225489B1 (en) 1993-12-28 2001-05-01 Mona Industries, Inc. Silicone modified phospholipid compositions
FR2718961B1 (fr) 1994-04-22 1996-06-21 Oreal Compositions pour le lavage et le traitement des cheveux et de la peau à base de céramide et de polymères à groupements cationiques.
PE6995A1 (es) 1994-05-25 1995-03-20 Procter & Gamble Composicion que comprende un polimero de polialquilenoamina etoxilado propoxilado como agente de separacion de sucio
US5601858A (en) 1994-12-29 1997-02-11 Warner-Lambert Company Non-stick chewing gum
US5968881A (en) 1995-02-02 1999-10-19 The Procter & Gamble Company Phosphate built automatic dishwashing compositions comprising catalysts
ATE193320T1 (de) 1995-02-02 2000-06-15 Procter & Gamble Maschinengeschirrspülmittel zusammensetzungen mit kobalt chelatkatalysatoren
US6255367B1 (en) 1995-03-07 2001-07-03 Landec Corporation Polymeric modifying agents
US5849313A (en) 1995-04-12 1998-12-15 Mona Industries, Inc. Silicone modified phospholipid compositions
US5674832A (en) 1995-04-27 1997-10-07 Witco Corporation Cationic compositions containing diol and/or diol alkoxylate
US5597936A (en) 1995-06-16 1997-01-28 The Procter & Gamble Company Method for manufacturing cobalt catalysts
EP0832175B1 (fr) 1995-06-16 2001-07-25 The Procter & Gamble Company Compositions d'agents de blanchiment comprenant des catalyseurs au cobalt
US5581005A (en) 1995-06-16 1996-12-03 The Procter & Gamble Company Method for manufacturing cobalt catalysts
BR9609284A (pt) 1995-06-16 1999-05-11 Procter & Gamble Composições para lavar louça em máquina automática compreendendo catalisadores de cobalto
US5916862A (en) 1995-06-20 1999-06-29 The Procter & Gamble Company Detergent compositions containing amines and anionic surfactants
US5583090A (en) 1995-06-26 1996-12-10 Monsanto Company Herbicidal microencapsulated clomazone compositions with reduced vapor transfer
US5559261A (en) 1995-07-27 1996-09-24 The Procter & Gamble Company Method for manufacturing cobalt catalysts
EP0859594B1 (fr) 1995-10-16 2001-08-22 The Procter & Gamble Company Shampoings revitalisants a base de polyalkyleneglycol
US5703034A (en) 1995-10-30 1997-12-30 The Procter & Gamble Company Bleach catalyst particles
WO1997016517A1 (fr) 1995-10-30 1997-05-09 The Procter & Gamble Company Compositions detergentes liquides epaissies, tres aqueuses, economiques
JP3059221B2 (ja) 1995-12-20 2000-07-04 ザ、プロクター、エンド、ギャンブル、カンパニー ブリーチ触媒プラス酵素粒子
US5776443A (en) 1996-03-18 1998-07-07 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Hair care compositions
US5759990A (en) 1996-10-21 1998-06-02 The Procter & Gamble Company Concentrated fabric softening composition with good freeze/thaw recovery and highly unsaturated fabric softener compound therefor
AR006355A1 (es) 1996-03-22 1999-08-25 Procter & Gamble Activo suavizante biodegradable y composicion que lo contiene
US5756436A (en) 1996-03-27 1998-05-26 The Procter & Gamble Company Conditioning shampoo compositions containing select cationic conditioning polymers
US5932203A (en) 1996-03-27 1999-08-03 Proctor & Gamble Company Conditioning shampoo compositions containing select hair conditioning esters
US5935561A (en) 1996-03-27 1999-08-10 Procter & Gamble Company Conditioning shampoo compositions containing select hair conditioning agents
US5958870A (en) 1996-04-01 1999-09-28 The Procter & Gamble Company Betaine ester compounds of active alcohols
DE19617983A1 (de) 1996-05-06 1997-11-13 Basf Ag ß-Hydroxyalkylvinylamin-Einheiten enthaltende Polymerisate, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2751532B1 (fr) 1996-07-23 1998-08-28 Oreal Compositions lavantes et conditionnantes a base de silicone et de dialkylether
US5929022A (en) 1996-08-01 1999-07-27 The Procter & Gamble Company Detergent compositions containing amine and specially selected perfumes
US6147037A (en) 1996-08-19 2000-11-14 The Procter & Gamble Company Fragrance delivery systems
CN1233281A (zh) 1996-08-19 1999-10-27 普罗格特-甘布尔公司 包含β酮酯香料前体的手洗洗衣洗涤剂组合物
US6093691A (en) 1996-08-19 2000-07-25 The Procter & Gamble Company Rinse added fabric softening compositions and method of use for the delivery of fragrance derivatives
US5914307A (en) 1996-10-15 1999-06-22 The Procter & Gamble Company Process for making a high density detergent composition via post drying mixing/densification
US6200554B1 (en) 1996-10-16 2001-03-13 The Procter & Gamble Company Conditioning shampoo compositions having improved silicone deposition
CN1244212A (zh) 1996-10-21 2000-02-09 普罗格特-甘布尔公司 浓缩的织物柔软组合物
ZA9711272B (en) 1996-12-19 1998-06-23 Procter & Gamble Dryer-activated fabric conditioning and antistatic compositions with improved perfume longevity.
ZA9711269B (en) 1996-12-19 1998-06-23 Procter & Gamble Dryer added fabric softening compositions and method of use for the delivery of fragrance derivatives.
US6069122A (en) 1997-06-16 2000-05-30 The Procter & Gamble Company Dishwashing detergent compositions containing organic diamines for improved grease cleaning, sudsing, low temperature stability and dissolution
US5990065A (en) 1996-12-20 1999-11-23 The Procter & Gamble Company Dishwashing detergent compositions containing organic diamines for improved grease cleaning, sudsing, low temperature stability and dissolution
AU730956B2 (en) 1996-12-23 2001-03-22 Ciba Specialty Chemicals Water Treatments Limited Particles containing absorbed liquids and methods of making them
US6297203B1 (en) 1997-05-05 2001-10-02 The Procter & Gamble Styling shampoo compositions containing cationic styling polymers and cationic deposition polymers
EP0991615B1 (fr) 1997-06-27 2002-08-14 The Procter & Gamble Company Acetals et cetals lineaires precurseurs de parfum
US5968286A (en) 1997-10-03 1999-10-19 Helene Curtis, Inc. Heat-mediated conditioning from shampoo and conditioner hair care compositions containing silicone
US6492462B2 (en) 1998-01-16 2002-12-10 Landec Corporation Side chain crystalline polymer as rheology modifier for crosslinked polymer
SG93823A1 (en) 1998-02-13 2003-01-21 Givaudan Roure Int Aryl-acrylic acid esters
JP2002504548A (ja) 1998-02-24 2002-02-12 ザ、プロクター、エンド、ギャンブル、カンパニー 調整しうるフレグランス原料アルコール放出速度を有した新規な環式プロ香料
EP0952142B1 (fr) 1998-04-20 2006-10-18 Givaudan SA Composés ayant des groupes hydroxyles protégés
US6479682B1 (en) 1998-04-20 2002-11-12 Givaudan Sa Compounds having protected hydroxy groups
US6133228A (en) 1998-05-28 2000-10-17 Firmenich Sa Slow release of fragrant compounds in perfumery using 2-benzoyl benzoates, 2-alkanoyl benzoates or α-keto esters
DE19835114A1 (de) 1998-08-04 2000-02-10 Basf Ag Mikrokapseln aus formaldehydarmen Melamin-Formaldehydharzen
DE19840583A1 (de) 1998-09-05 2000-03-09 Bayer Ag Mikrokapsel-Formulierungen
ID29488A (id) 1998-10-23 2001-08-30 Procter & Gamble Keharuman serasi dan kepustakaan keharuman aldehid dan keton
WO2000059616A1 (fr) 1999-04-07 2000-10-12 Petramec, Inc. Procede de fabrication et d'utilisation de microcapsules a densite regulee
ATE460153T1 (de) 1999-06-01 2010-03-15 Procter & Gamble Riechstoffvorläufer
US6861402B1 (en) 1999-06-01 2005-03-01 The Procter & Gamble Company Pro-fragrances
BR0012673B1 (pt) 1999-07-20 2011-01-25 partìcula de óleo encapsulada, processo para preparação da mesma, e composição de limpeza granular ou seu componente contendo uma partìcula de óleo encapsulada.
US6287603B1 (en) 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
US6271192B1 (en) 1999-11-10 2001-08-07 National Starch And Chemical Investment Holding Company Associative thickener for aqueous fabric softener
EP1116788A1 (fr) 2000-01-12 2001-07-18 The Procter & Gamble Company Composition de pro-parfum
WO2001068234A1 (fr) 2000-03-17 2001-09-20 Bayer Aktiengesellschaft Suspensions en microcapsules
DE10021165A1 (de) 2000-04-29 2001-11-08 Henkel Kgaa System für die Freisetzung von Wirkstoffen
SG98393A1 (en) 2000-05-19 2003-09-19 Inst Materials Research & Eng Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
US6610646B2 (en) 2000-06-01 2003-08-26 The Procter & Gamble Company Enhanced duration fragrance delivery system having a non-distorted initial fragrance impression
US20020094938A1 (en) 2000-11-08 2002-07-18 The Procter & Gamble Company Photo-labile pro-fragrance conjugates
US6610648B2 (en) 2000-12-22 2003-08-26 Givaudan Sa Malodor counteractant compositions
JP2004525271A (ja) 2001-03-07 2004-08-19 ザ プロクター アンド ギャンブル カンパニー 残留洗剤が存在する場合に使用する濯ぎ添加布帛コンディショニング組成物
US6956013B2 (en) 2001-04-10 2005-10-18 The Procter & Gamble Company Photo-activated pro-fragrances
DE10122898A1 (de) 2001-05-11 2002-11-14 Haarmann & Reimer Gmbh Verwendung von Hydroxyflavanonen zur Maskierung des bitteren Geschmacks
US20030073607A1 (en) 2001-05-11 2003-04-17 The Procter & Gamble Company Pro-perfume compositions
US6942874B2 (en) 2001-05-25 2005-09-13 Linguagen Corp. Nucleotide compounds that block the bitter taste of oral compositions
US20030125220A1 (en) 2001-09-11 2003-07-03 The Procter & Gamble Company Compositions comprising photo-labile perfume delivery systems
US6986709B2 (en) 2001-09-21 2006-01-17 Igt Gaming device having games with variable game functions
GB2380936B (en) 2001-10-18 2003-07-09 Reckitt Benckiser Healthcare Improvements in or relating to compositions
EP1314777A1 (fr) 2001-11-27 2003-05-28 The Procter & Gamble Company Compositions précurseur de parfum utilisées dans des produits de nettoyage et traitement de tissus
GB2382586A (en) 2001-12-03 2003-06-04 Procter & Gamble Fabric treatment compositions
DE10226942A1 (de) 2002-06-17 2003-12-24 Symrise Gmbh & Co Kg Verwendung von Mandelsäurealkylamiden als Aromastoffe
DE10227462A1 (de) 2002-06-20 2004-01-08 Symrise Gmbh & Co. Kg Herstellung von cis-Pellitorin und Verwendung als Aromastoff
US6492315B1 (en) 2002-07-31 2002-12-10 Colgate-Palmolive Company Unit dose nonaqueous liquid softener disposed in water soluble container
US7473467B2 (en) 2002-09-03 2009-01-06 Firmenich Sa Preparation of microcapsules
US8187580B2 (en) 2002-11-01 2012-05-29 The Procter & Gamble Company Polymeric assisted delivery using separate addition
DE10253331A1 (de) 2002-11-14 2004-06-03 Symrise Gmbh & Co. Kg Verwendung von trans-Pellitori als Aromastoff
EP1569513A1 (fr) 2002-12-13 2005-09-07 Monsanto Technology LLC Microcapsules a vitesse de liberation regulee par une amine
EP1431382A1 (fr) 2002-12-19 2004-06-23 The Procter & Gamble Company Produit pour le traitement de tissus à dose unitaire, à compartiment unique et comprenant des compositions ensachées avec des agents adoucissants non-cationiques
US7135451B2 (en) 2003-03-25 2006-11-14 The Procter & Gamble Company Fabric care compositions comprising cationic starch
US7365043B2 (en) 2003-06-27 2008-04-29 The Procter & Gamble Co. Lipophilic fluid cleaning compositions capable of delivering scent
WO2005006881A2 (fr) 2003-07-09 2005-01-27 Virginia Commonwealth University Modification du gout de sel
FR2857895B1 (fr) 2003-07-23 2007-01-26 Soitec Silicon On Insulator Procede de preparation de surface epiready sur films minces de sic
EP1502646B1 (fr) 2003-08-01 2016-07-13 The Procter & Gamble Company Microcapsules
DE10351422A1 (de) 2003-11-04 2005-06-16 Symrise Gmbh & Co. Kg Verwendung von Alkencarbonsäure-N-alkylamiden als Aromastoffe
DE602004007403T3 (de) 2003-12-19 2014-10-30 Unilever N.V. Waschmittelgranulat und herstellungsverfahren
BRPI0509679A (pt) 2004-04-09 2007-10-09 Unilever Nv granulado para uso em produto de limpeza particulado, processo de fabricação do mesmo e composição detergente
DE102004032878A1 (de) 2004-07-07 2006-02-16 Symrise Gmbh & Co. Kg Verwendung von Alkyloxyalkansäureamiden insbesondere als Aromastoffe sowie neue Alkyloxyalkansäureamide
MX2007012949A (es) 2005-04-18 2008-01-11 Procter & Gamble Composiciones diluidas para el cuidado de telas, que comprenden espesantes, y composiciones para el cuidado de telas que se utilizan en presencia de remanentes anionicos.
US20060248665A1 (en) 2005-05-06 2006-11-09 Pluyter Johan G L Encapsulated fragrance materials and methods for making same
US20070138673A1 (en) 2005-12-15 2007-06-21 Kaiping Lee Process for Preparing a High Stability Microcapsule Product and Method for Using Same
DK1840145T3 (en) * 2006-03-30 2018-02-12 Fmc Corp Microcapsules of acetylenecarbamide derivatives-polyurea polymers and controlled release formulations
WO2007112891A1 (fr) 2006-04-04 2007-10-11 Unilever Plc Composition de lavage du linge comprenant un agent benefique liquide encapsule
JP5367565B2 (ja) 2006-05-05 2013-12-11 ザ プロクター アンド ギャンブル カンパニー マイクロカプセルを有するフィルム
US20070275866A1 (en) 2006-05-23 2007-11-29 Robert Richard Dykstra Perfume delivery systems for consumer goods
GB0611486D0 (en) 2006-06-09 2006-07-19 Unilever Plc Fabric softener composition
US7833960B2 (en) 2006-12-15 2010-11-16 International Flavors & Fragrances Inc. Encapsulated active material containing nanoscaled material
FR2912749B1 (fr) 2007-02-19 2009-04-24 Snf Soc Par Actions Simplifiee Copolymeres cationiques derives d'acrylamide et leur utilisations
AU2008303602A1 (en) 2007-09-27 2009-04-02 F. Hoffmann-La Roche Ag Quinoline derivatives as 5HT5A receptor antagonists
US9763861B2 (en) 2008-12-04 2017-09-19 International Flavors & Fragrances Inc. Stable, flowable silica capsule formulation
US20140287008A1 (en) 2008-12-04 2014-09-25 International Flavors & Fragrances Inc. Hybrid polyurea fragrance encapsulate formulation and method for using the same
EP2204155A1 (fr) 2008-12-30 2010-07-07 Takasago International Corporation Composition odorante pour microcapsules cýur/enveloppe
US8524785B2 (en) 2009-09-04 2013-09-03 International Flavors And Fragrances Inc. Methods for using rebaudioside C as a flavor enhancer
US8299011B2 (en) 2009-09-18 2012-10-30 International Flavors & Fragrances Inc. Encapsulated active materials
US10085925B2 (en) * 2009-09-18 2018-10-02 International Flavors & Fragrances Inc. Polyurea capsule compositions
WO2015023961A1 (fr) 2013-08-15 2015-02-19 International Flavors & Fragrances Inc. Capsules en polyurée ou polyuréthane
US11311467B2 (en) 2009-09-18 2022-04-26 International Flavors & Fragrances Inc. Polyurea capsules prepared with a polyisocyanate and cross-linking agent
US10226405B2 (en) 2009-09-18 2019-03-12 International Flavors & Fragrances Inc. Purified polyurea capsules, methods of preparation, and products containing the same
CA2682636C (fr) 2009-11-05 2010-06-15 The Procter & Gamble Company Additif a parfumer une buanderie
MX2012015199A (es) 2010-06-22 2013-01-24 Procter & Gamble Sistemas de perfume.
BR112013014712B1 (pt) 2010-12-14 2021-03-02 The Goverment Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services primeiro e segundo vetores de adenovírus recombinantes
US8333289B2 (en) 2011-01-07 2012-12-18 The Procter & Gamble Company Package for laundry scent additive
US20120294821A1 (en) 2011-05-20 2012-11-22 International Flavors & Fragrances Inc. Low Volatile Reactive Malodor Counteractives and Methods of Use Thereof
MX351211B (es) 2011-06-23 2017-10-04 Procter & Gamble Sistemas de perfume.
BR102012027933A2 (pt) * 2011-11-01 2015-11-17 Dow Agrosciences Llc composições pesticidas estáveis
CN104066828B (zh) 2012-01-18 2017-06-06 宝洁公司 香料体系
US9233768B2 (en) 2012-02-27 2016-01-12 The Procter & Gamble Company Method of rejecting a defective unit dose pouch from a manufacturing line
US20130284637A1 (en) 2012-04-30 2013-10-31 Danisco Us Inc. Unit-dose format perhydrolase systems
BR112015000749B1 (pt) 2012-07-13 2020-02-18 International Flavors & Fragrances Inc. Cápsula de fragrância de hidrogel, formulações e processo para preparação das mesmas
US20150305380A1 (en) 2013-12-23 2015-10-29 International Flavors & Fragrances Inc. Transglucosylated rubus suavissimus extract and methods of preparation and use
US20150272184A1 (en) 2014-03-27 2015-10-01 International Flavors & Fragrances Inc. Naringenin and salts thereof for sweetness enhancement
CN104018357A (zh) * 2014-06-12 2014-09-03 常州美胜生物材料有限公司 一种用于织物整理上的微胶囊
US20150366252A1 (en) 2014-06-24 2015-12-24 International Flavors & Fragrances Inc. Sweetener enhancers and methods for using the same
US10369094B2 (en) * 2015-01-12 2019-08-06 International Flavors & Fragrances Inc. Hydrogel capsules and process for preparing the same
US11224569B2 (en) * 2015-01-12 2022-01-18 International Flavors & Fragrances Inc. Hydrogel capsules and process for preparing the same
EP3265183A1 (fr) * 2015-03-03 2018-01-10 The Procter and Gamble Company Compositions de revitalisant capillaire dotées de microcapsules
US20190184364A1 (en) * 2016-05-03 2019-06-20 International Flavors & Fragrances Inc. Fragrance compositions containing microcapsules
US20220008886A1 (en) * 2016-05-03 2022-01-13 International Flavors & Fragrances Inc. Biodegradable microcapsules
WO2017192648A1 (fr) * 2016-05-03 2017-11-09 International Flavors & Fragrances Inc. Microcapsules rechargeables
US11540985B2 (en) * 2016-07-01 2023-01-03 International Flavors & Fragrances Inc. Stable microcapsule compositions

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6930078B2 (en) * 2002-04-22 2005-08-16 The Procter & Gamble Company Shampoo containing a cationic guar derivative
US20070042182A1 (en) * 2003-05-11 2007-02-22 Arie Markus Encapsulated essential oils
US20130337023A1 (en) * 2009-09-18 2013-12-19 International Flavors & Fragrances Inc. Polyurea capsules prepared with aliphatic isocyanates and amines
US9738817B2 (en) * 2012-10-09 2017-08-22 Avery Dennison Corporation Adhesives and related methods
US20160184196A1 (en) * 2014-12-16 2016-06-30 The Procter & Gamble Company Compositions Providing Delayed Release of Actives
WO2016144798A1 (fr) * 2015-03-06 2016-09-15 International Flavors & Fragrances Inc. Compositions à microcapsule haute performance

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11326133B2 (en) * 2018-04-10 2022-05-10 Rohm And Haas Company Anti-redeposition additive for laundry detergent
US20210371349A1 (en) * 2018-04-25 2021-12-02 Oms Investments, Inc. Fertilizer compositions having slow-release nitrogen compounds and methods of forming thereof
US20220408745A1 (en) * 2019-09-13 2022-12-29 Meiji Co., Ltd. Solid food and solid milk having hole penetrating first face and second face
US12130534B2 (en) 2019-12-23 2024-10-29 E Ink Corporation Color electrophoretic layer including microcapsules with nonionic polymeric walls
US11747701B2 (en) 2019-12-23 2023-09-05 E Ink Corporation Color electrophoretic layer including microcapsules with nonionic polymeric walls
CN115003409A (zh) * 2020-01-29 2022-09-02 奇华顿股份有限公司 方法
US11905223B2 (en) * 2020-03-20 2024-02-20 Oms Investments, Inc. Fertilizer compositions having slow-release nitrogen compounds and methods of forming thereof
US20210292252A1 (en) * 2020-03-20 2021-09-23 Oms Investments, Inc. Fertilizer compositions having slow-release nitrogen compounds and methods of forming thereof
CN112293414A (zh) * 2020-09-28 2021-02-02 广州立白企业集团有限公司 杀菌除异味的组合物及其制备方法
US20220152573A1 (en) * 2020-11-19 2022-05-19 The Procter & Gamble Company Consumer product comprising biodegradable delivery particles
US20220195350A1 (en) * 2020-12-23 2022-06-23 The Procter & Gamble Company Anti-microbial liquid detergent composition
US12091643B2 (en) 2020-12-23 2024-09-17 The Procter & Gamble Company Process of removing microorganism from an article of clothing
WO2023030855A1 (fr) * 2021-08-31 2023-03-09 Givaudan Sa Neutralisation de mauvaises odeurs
WO2023028800A1 (fr) * 2021-08-31 2023-03-09 Givaudan Sa Neutralisation des odeurs
CN115725252A (zh) * 2022-11-25 2023-03-03 浙江福斯特新材料研究院有限公司 树脂组合物、母粒、液体胶黏剂、胶膜及应用

Also Published As

Publication number Publication date
CN116764558A (zh) 2023-09-19
WO2018053356A1 (fr) 2018-03-22
EP4209264A1 (fr) 2023-07-12
CN109689197B (zh) 2023-06-23
MX2019003078A (es) 2019-07-08
CN109689197A (zh) 2019-04-26
EP3512625B1 (fr) 2023-04-26
EP3512625A1 (fr) 2019-07-24
BR112019005017A2 (pt) 2019-06-04
EP3512625A4 (fr) 2020-05-20
ES2950434T3 (es) 2023-10-10
US20210268467A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
EP3512625B1 (fr) Compositions de microcapsules stabilisées avec des agents de régulation de viscosité
US12013574B2 (en) Stable microcapsule compositions
US10555879B2 (en) Polyurea capsule compositions
EP3897955B1 (fr) Microcapsules d'hydroxyéthylcellulose
US11491089B2 (en) Reloadable microcapsules
US10537503B2 (en) Microcapsule compositions with high performance
EP3416610B1 (fr) Composition de microcapsules
US20180272308A1 (en) Hybrid capsules
EP3300794A2 (fr) Compositions de microcapsules contenant un silicone aminé
US20180015009A1 (en) Microcapsule compositions with improved deposition
US20160166480A1 (en) Microcapsule compositions
US20190224086A1 (en) Microcapsule compositions with improved deposition
BR112019005017B1 (pt) Composição de microcápsula

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

AS Assignment

Owner name: INTERNATIONAL FLAVORS & FRAGRANCES INC., NEW YORK

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:POSTMA, DJURRE SIJBREN;LEI, YABIN;LEE, HUI MIN;AND OTHERS;SIGNING DATES FROM 20160923 TO 20161011;REEL/FRAME:055162/0853

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION